xiaoniu2021的个人主页 - 老虎社区

xiaoniu2021

xiaoniu2021

暂无个人介绍

IP属地：未知

73关注

1粉丝

0主题

0勋章

2021-06-08

Please like and comment for me

Amazon Stock: Has It Produced The Most Alpha In Big Tech?

2021-06-14

Pls comment and like with many thanks

抱歉，原内容已删除

2021-06-22

Nice

Stocks making the biggest moves after hours: Sanderson Farms, Globalstar & more

2021-06-12

Cool

抱歉，原内容已删除

2021-06-07

Yea

抱歉，原内容已删除

2021-06-22

Like and comment. Thank you

抱歉，原内容已删除

2021-06-17

Like and comment pls. Thanks 😊

抱歉，原内容已删除

2021-06-08

Nice

Opinion: Only ‘greedy’ drug companies will cure Alzheimer’s

2021-06-07

Hmm

Colorado Governor Wants to Allow Residents to Pay State Taxes in Crypto

2021-06-07

Good

抱歉，原内容已删除

2021-06-24

Like.and comments pls

HK-listed Agile climbs most in 5 weeks on theme park project with Melco

2021-06-14

Good

抱歉，原内容已删除

2021-06-26

Hmmm

Is Apple A Better Buy Than Other FAANG Stocks?

2021-06-18

Pls like and comment. Thanks

抱歉，原内容已删除

2021-06-06

Good

抱歉，原内容已删除

2021-07-14

Good night bro

@Heibi:$AMC Entertainment(AMC)$Time to sleep lol gd night all 💎👐

2021-06-22

The market pulled back after the latest Fed meeting on Wednesday, where policymakers signaled they expect to raise interest rates by late 2023, sooner than they had previously anticipated. The selloff intensified Friday after St. Louis Fed President James Bullard told CNBC he sees the Fed starting to raise interest rates in late 2022.Now is a time to be looking to add stocks to one's watchlist, but why do the stocks chosen above stand out? Before turning to that question, it is important to consider how one goes about choosing a stock in the first place. Superior fundamentals and technical action, and buying at the right time, are all part of a shrewd investing formula.

5 Ultra-Popular Stocks Wall Street Views as Overvalued

2021-06-19

Good say. Oil is back

抱歉，原内容已删除

2021-06-10

Zhun bo

Company spending is 'going ballistic.' Wall Street analysts expect these stocks to benefit

2021-06-08

Sad case for me

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3582279635767115","uuid":"3582279635767115","gmtCreate":1619187349090,"gmtModify":1622772964080,"name":"xiaoniu2021","pinyin":"xiaoniu2021","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":73,"tweetSize":25,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.13","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.26%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":144127981,"gmtCreate":1626272599843,"gmtModify":1631893946598,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Good night bro","listText":"Good night bro","text":"Good night bro","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/144127981","repostId":"144126462","repostType":1,"repost":{"id":144126462,"gmtCreate":1626272507556,"gmtModify":1633928396670,"author":{"id":"3571397064539484","authorId":"3571397064539484","name":"Heibi","avatar":"https://static.tigerbbs.com/a4b0cb7e69d4c38018b1a3a840f08834","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3571397064539484","idStr":"3571397064539484"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Time to sleep lol gd night all 💎👐","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Time to sleep lol gd night all 💎👐","text":"$AMC Entertainment(AMC)$Time to sleep lol gd night all 💎👐","images":[{"img":"https://static.tigerbbs.com/5f51c54dc6d43d9c611bbc07ccb85dbf","width":"1284","height":"2457"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/144126462","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":290,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":125407689,"gmtCreate":1624683557641,"gmtModify":1631893946601,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Hmmm","listText":"Hmmm","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/125407689","repostId":"1108941456","repostType":4,"repost":{"id":"1108941456","pubTimestamp":1624664800,"share":"https://www.laohu8.com/m/news/1108941456?lang=&edition=full","pubTime":"2021-06-26 07:46","market":"us","language":"en","title":"Is Apple A Better Buy Than Other FAANG Stocks?","url":"https://stock-news.laohu8.com/highlight/detail?id=1108941456","media":"seekingalpha","summary":"Apple undoubtedly is a great company, with a strong brand, excellent margins, and fundamentals, a fortress balance sheet, and massive shareholder returns.Being a great company does not mean that the stock must be a great buy. However, valuations are significantly higher than they were historically.I believe that some of the other FAANG stocks are better, while others are worse. AAPL seems like a solid, but not a spectacular investment at today's valuation.At 26-64x this year's expected net profi","content":"<p><b>Summary</b></p>\n<ul>\n <li>Apple undoubtedly is a great company, with a strong brand, excellent margins, and fundamentals, a fortress balance sheet, and massive shareholder returns.</li>\n <li>Being a great company does not mean that the stock must be a great buy. However, valuations are significantly higher than they were historically.</li>\n <li>I believe that some of the other FAANG stocks are better, while others are worse. AAPL seems like a solid, but not a spectacular investment at today's valuation.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8bb49d385ec6d3044db2f4474cbb2c57\" tg-width=\"1536\" tg-height=\"1024\" referrerpolicy=\"no-referrer\"><span>MagioreStock/iStock Editorial via Getty Images</span></p>\n<p><b>Article Thesis</b></p>\n<p>Going with FAANG stocks, i.e. Facebook (FB), Apple (AAPL), Amazon (AMZN), Netflix (NFLX), and Alphabet (GOOG)(GOOGL), has been a winning trade in recent years, as those companies delivered strong gains for their owners. These companies do, however, differ quite a lot from each other in a range of metrics, including growth, valuation, and there are also differences when it comes to each company's specific risks and moat. Apple is the largest company of these in terms of profits and market capitalization, but that does not necessarily make it the best investment. In this report, we will take a look at how Apple compares versus the other FAANG members.</p>\n<p><b>Are FAANG Stocks A Good Investment?</b></p>\n<p>Looking back a couple of years, the answer is pretty clear that FAANG stocks at least<i>were</i>a good investment in the recent past:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ae2b8e2b9caf99f74c28bafc10a0a872\" tg-width=\"635\" tg-height=\"484\"><span>Data by YCharts</span></p>\n<p>With gains of 200% to 460%, these five companies easily trounced the broad market's returns over the same time, and all led to hefty gains, at least tripling an investor's money in just five years. The factors that led to these strong gains do, at least partially, still exist today. Notably, these five companies are generating compelling earnings growth, have leadership positions in the markets they address, possess strong brands that are well-received by consumers, and seem to have strong, long-term-oriented leadership teams.</p>\n<p>These factors are still in place today, which indicates that FAANG stocks could also be good investments in coming years, although investors should, even with high-quality companies, also consider a stock's valuation. Today, these companies do not look extremely cheap in most cases:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2ef865eea7af4369048432a9c85d1d83\" tg-width=\"635\" tg-height=\"540\"><span>Data by YCharts</span></p>\n<p>At 26-64x this year's expected net profits, FAANG stocks can't really be called bargains, although the above-average valuations are, at least to some degree, justified due to the above-average earnings growth that these companies do generate. In any case, I doubt that investors owning FAANG stocks today will see 200%-400%+ returns over the next five years, as this seems unlikely for each of these five stocks due to the combination of current valuations and expected earnings growth. This does, however, not mean that FAANG stocks must be bad investments or underperform the market. In fact, in recent articles, I showcased that solid or even quite attractive returns can be expected from&nbsp;Facebook,Amazon, and Apple, even though the 30%-50% annual returns are likely a thing of the past - that's just mathematics, as no stock can grow at that rate forever.</p>\n<p><b>What Investors Can Expect From Apple</b></p>\n<p>Apple Inc. is not the highest-growth FAANG stock at all. Its growth has been solid but not spectacular in the recent past. This isn't a large surprise, as there is only a certain number of consumers that want to buy an iPhone or an iPad, and that amount can't grow by 50% a year for a very long time. Nevertheless, due to some market growth, some price increases, and growth from its services business, Apple should still be able to deliver sizeable revenue growth in the long run. New products such as the car project are a potential wildcard, but at least for the foreseeable future, this will not be a major profit center for the company. Apple also has a very ambitious shareholder return program, and its buybacks are an important factor for its future earnings per share growth. I believe that, overall, a high-single-digit earnings per share growth rate will be very much achievable for Apple in the long run. Combined with some multiple depression that I expect in coming years, as Apple will likely not trade at a high-20s earnings multiple forever, this gets me to a total return estimate&nbsp;in the 7% range. This is significantly less compared to what investors saw over the last couple of years, but on the other hand, 7% annual returns stemming from a strong, stable blue-chip stock such as Apple are not unattractive. I believe that some of the FAANG stocks could deliver stronger returns, primarily Alphabet and Facebook.</p>\n<p><b>Apple Versus Facebook</b></p>\n<p>Both Apple Inc. and Facebook have a great market position, but Facebook is even more dominant in its industry compared to Apple. Apple has, in the smartphone industry, a market share of around 20%, although more in the higher-end segments. Facebook, for comparison, owns four out of the top five social media networks, with Facebook, Instagram, Facebook Messenger, and WhatsApp. Clearly, FB absolutely dominates its industry. Facebook's industry is also growing quicker than the hardware IT markets that Apple serves, which is why Facebook's growth was significantly higher than Apple's growth in the recent past:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8fd8043ca75dcb2c38f5ffa427c8c0b9\" tg-width=\"635\" tg-height=\"433\"><span>Data by YCharts</span></p>\n<p>Facebook grew its revenue by well above 300% over the last five years, while Apple's revenue grew by a little less than 50%. When we look back at the total return chart at the beginning of this article and compare it to this revenue chart, we see that Apple's returns stemmed from multiple expansion to a large degree, whereas Facebook's stock actually got less expensive over the last five years. Facebook's business growth clearly outpaced its share price gains, which has made its shares less expensive. This also explains why Facebook, today, trades below the long-term median earnings multiple, whereas Apple's valuation is at the higher end of the historic range:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d3d49e0007aa77608b2992a9fef2142d\" tg-width=\"635\" tg-height=\"481\"><span>Data by YCharts</span></p>\n<p>The fact that Facebook trades at a historic discount points to a solid entry price, whereas the same can't be said about Apple. On top of that, Facebook will also grow much faster in the future - at least if the analyst community is correct:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6b16c9b3e2eac182d42686bcd8a98fc5\" tg-width=\"635\" tg-height=\"515\"><span>Data by YCharts</span></p>\n<p>While Apple is expected to see revenue growth of around 10% over the next two years, Facebook is expected to grow by 40% over the same time. Facebook's earnings per share growth estimate is also materially higher than that of Apple.</p>\n<p>To sum things up, we can say that Facebook is growing much faster, is even more dominant in its industry compared to Apple, and its shares are trading at a discount compared to the historic average, whereas Apple's shares are historically expensive. This combination makes me believe that the total return outlook for Facebook is better compared to that of Apple.</p>\n<p><b>Apple Versus Alphabet</b></p>\n<p>When we compare Apple to Alphabet, the comparison is relatively similar to what we just saw when comparing Applet to Facebook. Alphabet is a company that is growing quicker than Apple, and that can, to a large degree, be explained by its great market position and the higher market growth rate. Online advertising is a market that has been growing quicker than the tablet or smartphone market in recent years, and the same will, I believe, be true in the foreseeable future as well.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6360514d097081c546a0ccacfbdc7af6\" tg-width=\"635\" tg-height=\"450\"><span>Data by YCharts</span></p>\n<p>Alphabet is forecasted to grow its revenue by more than 30% over the next two years, versus Apple's 10% growth. On top of that, at close to 20%, Alphabet is also expected to grow its earnings per share at a higher rate.</p>\n<p>Nevertheless, despite its significantly better growth forecast, Alphabet isn't a lot more expensive compared to Apple. GOOG trades at 29x forward earnings, versus AAPL's 26x forward earnings multiple. Does it make sense for GOOG to trade at a premium of just 10%, while its expected growth is one and a half times as high as that of AAPL? You be the judge, but to me, it seems like the valuation looks better at Alphabet as long as we account for the stronger growth expectations. On top of that, with a net cash position of around $120 billion, Alphabet also has one of the best balance sheets in the world. Apple, for comparison, has a somewhat<i>smaller</i>net cash position of $80 billion, although that still makes for a very strong balance sheet, of course.</p>\n<p>All in all, we can summarize that Alphabet is growing faster today, is expected to grow significantly faster in the next two years and in the long run, has an even better balance sheet and a more dominant market position, and yet it trades at an earnings multiple that is only 10% higher than that of Apple. To me, Alphabet thus looks like the more attractive pick among these two at current prices.</p>\n<p><b>Apple Versus Netflix And Amazon</b></p>\n<p>Looking at the last two remaining companies in the FAANG group, we see that, once again, AAPL is growing at a slower pace. Unless Facebook and Alphabet, however, both Netflix and Amazon are way more expensive than Apple.</p>\n<p>This huge valuation premium offsets, at least to some degree, the higher expected growth, which is why I believe that Netflix and Amazon do not really seem like much better picks compared to Apple:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6ccc2536fa3cadf06639a89e0b211b9a\" tg-width=\"635\" tg-height=\"481\"><span>Data by YCharts</span></p>\n<p>AMZN and NFLX trade at PEG ratios of 1.8 and 1.9, which does not represent a clear discount compared to AAPL's valuation. On top of that, these two companies do not possess balance sheets that are as strong as that of Apple.</p>\n<p>Netflix, especially, looks significantly worse compared to the other FAANG members in terms of balance sheet strength and cash generation:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9d84f013051fbb00b6b488f5cfed66d4\" tg-width=\"635\" tg-height=\"450\"><span>Data by YCharts</span></p>\n<p>Netflix is the only FAANG member with a meaningful net debt position, and its free cash flows are equal to just 1% of its market capitalization. Netflix grows fast, but to me, it seems doubtful whether the current valuation is justified. Considering that more and more companies are pushing into the streaming market, including Disney (DIS), Amazon, and AT&amp;T(NYSE:T), more competition might hurt Netflix's margins in the future. NFLX thus seems like the worst pick among the five FAANG stocks to me, as it combines a high valuation, weak cash flows, and a somewhat uncertain competitive picture, and I think that is not fully negated by its strong growth alone.</p>\n<p>Amazon has a better market position than Netflix, a better balance sheet, and its valuation, relative to its growth, is a little lower than that of Netflix. I would rate Amazon as more or less equally attractive to Apple, although the two companies are quite different from each other in terms of growth, valuation, and shareholder returns.</p>\n<p><b>Which Is The Best FAANG Stock To Buy?</b></p>\n<p>Not every investor has the same goals, thus the answer may be different depending on what you are looking for in a stock. To me, Apple seems like a solid, but outstanding pick at current prices - the business undoubtedly is strong, the balance sheet is great, shareholder returns are hefty, but the valuation seems stretched, especially when we consider how cheap shares were in the past.</p>\n<p>Alphabet and Facebook do seem like the best FAANG picks to me today, as they combine strong growth with valuations that are only marginally higher than that of Apple. On top of that, both Alphabet and Facebook dominate their markets. Amazon is a stock that I would rate as a solid investment at today's price, so more or less in line with AAPL, whereas Netflix seems like the weakest pick among these five to me.</p>\n<p>Depending on your time horizon, appetite for risk, etc. you may disagree, however - and that's perfectly fine. I'd be glad to hear your top picks and reasoning in the comment section!</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Apple A Better Buy Than Other FAANG Stocks?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Apple A Better Buy Than Other FAANG Stocks?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-26 07:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4436558-apple-better-buy-faang-stocks><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nApple undoubtedly is a great company, with a strong brand, excellent margins, and fundamentals, a fortress balance sheet, and massive shareholder returns.\nBeing a great company does not mean ...</p>\n\n<a href=\"https://seekingalpha.com/article/4436558-apple-better-buy-faang-stocks\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://seekingalpha.com/article/4436558-apple-better-buy-faang-stocks","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108941456","content_text":"Summary\n\nApple undoubtedly is a great company, with a strong brand, excellent margins, and fundamentals, a fortress balance sheet, and massive shareholder returns.\nBeing a great company does not mean that the stock must be a great buy. However, valuations are significantly higher than they were historically.\nI believe that some of the other FAANG stocks are better, while others are worse. AAPL seems like a solid, but not a spectacular investment at today's valuation.\n\nMagioreStock/iStock Editorial via Getty Images\nArticle Thesis\nGoing with FAANG stocks, i.e. Facebook (FB), Apple (AAPL), Amazon (AMZN), Netflix (NFLX), and Alphabet (GOOG)(GOOGL), has been a winning trade in recent years, as those companies delivered strong gains for their owners. These companies do, however, differ quite a lot from each other in a range of metrics, including growth, valuation, and there are also differences when it comes to each company's specific risks and moat. Apple is the largest company of these in terms of profits and market capitalization, but that does not necessarily make it the best investment. In this report, we will take a look at how Apple compares versus the other FAANG members.\nAre FAANG Stocks A Good Investment?\nLooking back a couple of years, the answer is pretty clear that FAANG stocks at leastwerea good investment in the recent past:\nData by YCharts\nWith gains of 200% to 460%, these five companies easily trounced the broad market's returns over the same time, and all led to hefty gains, at least tripling an investor's money in just five years. The factors that led to these strong gains do, at least partially, still exist today. Notably, these five companies are generating compelling earnings growth, have leadership positions in the markets they address, possess strong brands that are well-received by consumers, and seem to have strong, long-term-oriented leadership teams.\nThese factors are still in place today, which indicates that FAANG stocks could also be good investments in coming years, although investors should, even with high-quality companies, also consider a stock's valuation. Today, these companies do not look extremely cheap in most cases:\nData by YCharts\nAt 26-64x this year's expected net profits, FAANG stocks can't really be called bargains, although the above-average valuations are, at least to some degree, justified due to the above-average earnings growth that these companies do generate. In any case, I doubt that investors owning FAANG stocks today will see 200%-400%+ returns over the next five years, as this seems unlikely for each of these five stocks due to the combination of current valuations and expected earnings growth. This does, however, not mean that FAANG stocks must be bad investments or underperform the market. In fact, in recent articles, I showcased that solid or even quite attractive returns can be expected from Facebook,Amazon, and Apple, even though the 30%-50% annual returns are likely a thing of the past - that's just mathematics, as no stock can grow at that rate forever.\nWhat Investors Can Expect From Apple\nApple Inc. is not the highest-growth FAANG stock at all. Its growth has been solid but not spectacular in the recent past. This isn't a large surprise, as there is only a certain number of consumers that want to buy an iPhone or an iPad, and that amount can't grow by 50% a year for a very long time. Nevertheless, due to some market growth, some price increases, and growth from its services business, Apple should still be able to deliver sizeable revenue growth in the long run. New products such as the car project are a potential wildcard, but at least for the foreseeable future, this will not be a major profit center for the company. Apple also has a very ambitious shareholder return program, and its buybacks are an important factor for its future earnings per share growth. I believe that, overall, a high-single-digit earnings per share growth rate will be very much achievable for Apple in the long run. Combined with some multiple depression that I expect in coming years, as Apple will likely not trade at a high-20s earnings multiple forever, this gets me to a total return estimate in the 7% range. This is significantly less compared to what investors saw over the last couple of years, but on the other hand, 7% annual returns stemming from a strong, stable blue-chip stock such as Apple are not unattractive. I believe that some of the FAANG stocks could deliver stronger returns, primarily Alphabet and Facebook.\nApple Versus Facebook\nBoth Apple Inc. and Facebook have a great market position, but Facebook is even more dominant in its industry compared to Apple. Apple has, in the smartphone industry, a market share of around 20%, although more in the higher-end segments. Facebook, for comparison, owns four out of the top five social media networks, with Facebook, Instagram, Facebook Messenger, and WhatsApp. Clearly, FB absolutely dominates its industry. Facebook's industry is also growing quicker than the hardware IT markets that Apple serves, which is why Facebook's growth was significantly higher than Apple's growth in the recent past:\nData by YCharts\nFacebook grew its revenue by well above 300% over the last five years, while Apple's revenue grew by a little less than 50%. When we look back at the total return chart at the beginning of this article and compare it to this revenue chart, we see that Apple's returns stemmed from multiple expansion to a large degree, whereas Facebook's stock actually got less expensive over the last five years. Facebook's business growth clearly outpaced its share price gains, which has made its shares less expensive. This also explains why Facebook, today, trades below the long-term median earnings multiple, whereas Apple's valuation is at the higher end of the historic range:\nData by YCharts\nThe fact that Facebook trades at a historic discount points to a solid entry price, whereas the same can't be said about Apple. On top of that, Facebook will also grow much faster in the future - at least if the analyst community is correct:\nData by YCharts\nWhile Apple is expected to see revenue growth of around 10% over the next two years, Facebook is expected to grow by 40% over the same time. Facebook's earnings per share growth estimate is also materially higher than that of Apple.\nTo sum things up, we can say that Facebook is growing much faster, is even more dominant in its industry compared to Apple, and its shares are trading at a discount compared to the historic average, whereas Apple's shares are historically expensive. This combination makes me believe that the total return outlook for Facebook is better compared to that of Apple.\nApple Versus Alphabet\nWhen we compare Apple to Alphabet, the comparison is relatively similar to what we just saw when comparing Applet to Facebook. Alphabet is a company that is growing quicker than Apple, and that can, to a large degree, be explained by its great market position and the higher market growth rate. Online advertising is a market that has been growing quicker than the tablet or smartphone market in recent years, and the same will, I believe, be true in the foreseeable future as well.\nData by YCharts\nAlphabet is forecasted to grow its revenue by more than 30% over the next two years, versus Apple's 10% growth. On top of that, at close to 20%, Alphabet is also expected to grow its earnings per share at a higher rate.\nNevertheless, despite its significantly better growth forecast, Alphabet isn't a lot more expensive compared to Apple. GOOG trades at 29x forward earnings, versus AAPL's 26x forward earnings multiple. Does it make sense for GOOG to trade at a premium of just 10%, while its expected growth is one and a half times as high as that of AAPL? You be the judge, but to me, it seems like the valuation looks better at Alphabet as long as we account for the stronger growth expectations. On top of that, with a net cash position of around $120 billion, Alphabet also has one of the best balance sheets in the world. Apple, for comparison, has a somewhatsmallernet cash position of $80 billion, although that still makes for a very strong balance sheet, of course.\nAll in all, we can summarize that Alphabet is growing faster today, is expected to grow significantly faster in the next two years and in the long run, has an even better balance sheet and a more dominant market position, and yet it trades at an earnings multiple that is only 10% higher than that of Apple. To me, Alphabet thus looks like the more attractive pick among these two at current prices.\nApple Versus Netflix And Amazon\nLooking at the last two remaining companies in the FAANG group, we see that, once again, AAPL is growing at a slower pace. Unless Facebook and Alphabet, however, both Netflix and Amazon are way more expensive than Apple.\nThis huge valuation premium offsets, at least to some degree, the higher expected growth, which is why I believe that Netflix and Amazon do not really seem like much better picks compared to Apple:\nData by YCharts\nAMZN and NFLX trade at PEG ratios of 1.8 and 1.9, which does not represent a clear discount compared to AAPL's valuation. On top of that, these two companies do not possess balance sheets that are as strong as that of Apple.\nNetflix, especially, looks significantly worse compared to the other FAANG members in terms of balance sheet strength and cash generation:\nData by YCharts\nNetflix is the only FAANG member with a meaningful net debt position, and its free cash flows are equal to just 1% of its market capitalization. Netflix grows fast, but to me, it seems doubtful whether the current valuation is justified. Considering that more and more companies are pushing into the streaming market, including Disney (DIS), Amazon, and AT&T(NYSE:T), more competition might hurt Netflix's margins in the future. NFLX thus seems like the worst pick among the five FAANG stocks to me, as it combines a high valuation, weak cash flows, and a somewhat uncertain competitive picture, and I think that is not fully negated by its strong growth alone.\nAmazon has a better market position than Netflix, a better balance sheet, and its valuation, relative to its growth, is a little lower than that of Netflix. I would rate Amazon as more or less equally attractive to Apple, although the two companies are quite different from each other in terms of growth, valuation, and shareholder returns.\nWhich Is The Best FAANG Stock To Buy?\nNot every investor has the same goals, thus the answer may be different depending on what you are looking for in a stock. To me, Apple seems like a solid, but outstanding pick at current prices - the business undoubtedly is strong, the balance sheet is great, shareholder returns are hefty, but the valuation seems stretched, especially when we consider how cheap shares were in the past.\nAlphabet and Facebook do seem like the best FAANG picks to me today, as they combine strong growth with valuations that are only marginally higher than that of Apple. On top of that, both Alphabet and Facebook dominate their markets. Amazon is a stock that I would rate as a solid investment at today's price, so more or less in line with AAPL, whereas Netflix seems like the weakest pick among these five to me.\nDepending on your time horizon, appetite for risk, etc. you may disagree, however - and that's perfectly fine. I'd be glad to hear your top picks and reasoning in the comment section!","news_type":1},"isVote":1,"tweetType":1,"viewCount":110,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":128641808,"gmtCreate":1624515467904,"gmtModify":1631893946604,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Like.and comments pls","listText":"Like.and comments pls","text":"Like.and comments pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/128641808","repostId":"2145012425","repostType":4,"isVote":1,"tweetType":1,"viewCount":263,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129947356,"gmtCreate":1624354790375,"gmtModify":1631893946605,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Like and comment.&nbsp; Thank you","listText":"Like and comment.&nbsp; Thank you","text":"Like and comment. Thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/129947356","repostId":"1186919064","repostType":4,"isVote":1,"tweetType":1,"viewCount":418,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120825133,"gmtCreate":1624319468622,"gmtModify":1631893946608,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/120825133","repostId":"1167650307","repostType":4,"isVote":1,"tweetType":1,"viewCount":317,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120330009,"gmtCreate":1624296497101,"gmtModify":1631883985890,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"The market pulled back after the latest Fed meeting on Wednesday, where policymakers signaled they expect to raise interest rates by late 2023, sooner than they had previously anticipated. The selloff intensified Friday after St. Louis Fed President James Bullard told CNBC he sees the Fed starting to raise interest rates in late 2022.Now is a time to be looking to add stocks to one's watchlist, but why do the stocks chosen above stand out? Before turning to that question, it is important to consider how one goes about choosing a stock in the first place. Superior fundamentals and technical action, and buying at the right time, are all part of a shrewd investing formula.","listText":"The market pulled back after the latest Fed meeting on Wednesday, where policymakers signaled they expect to raise interest rates by late 2023, sooner than they had previously anticipated. The selloff intensified Friday after St. Louis Fed President James Bullard told CNBC he sees the Fed starting to raise interest rates in late 2022.Now is a time to be looking to add stocks to one's watchlist, but why do the stocks chosen above stand out? Before turning to that question, it is important to consider how one goes about choosing a stock in the first place. Superior fundamentals and technical action, and buying at the right time, are all part of a shrewd investing formula.","text":"The market pulled back after the latest Fed meeting on Wednesday, where policymakers signaled they expect to raise interest rates by late 2023, sooner than they had previously anticipated. The selloff intensified Friday after St. Louis Fed President James Bullard told CNBC he sees the Fed starting to raise interest rates in late 2022.Now is a time to be looking to add stocks to one's watchlist, but why do the stocks chosen above stand out? Before turning to that question, it is important to consider how one goes about choosing a stock in the first place. Superior fundamentals and technical action, and buying at the right time, are all part of a shrewd investing formula.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/120330009","repostId":"2145084835","repostType":4,"repost":{"id":"2145084835","pubTimestamp":1624280460,"share":"https://www.laohu8.com/m/news/2145084835?lang=&edition=full","pubTime":"2021-06-21 21:01","market":"us","language":"en","title":"5 Ultra-Popular Stocks Wall Street Views as Overvalued","url":"https://stock-news.laohu8.com/highlight/detail?id=2145084835","media":"Motley Fool","summary":"If analysts are correct, these high-flying stocks will fizzle out over the next year.","content":"<p>Generally speaking, it pays to be bullish on Wall Street. Despite navigating its way through Black Monday in 1987, the dot-com bubble, the Great Recession, and more recently the coronavirus crash, the average annual total return for the benchmark <b>S&amp;P 500</b> since 1980, including dividends, is north of 11%.</p>\n<p>Not surprisingly, we see this optimism readily apparent in Wall Street's ratings on stocks. According to <b>FactSet</b>, more than half of all stocks carry a consensus buy rating, 38% have the equivalent of a hold rating, and just 7% are rated as sells. Yet, history shows that far more than 7% of stocks will eventually head lower.</p>\n<p>Based on Wall Street's consensus price targets, the following five ultra-popular stocks are all expected to lose value over the coming 12 months.</p>\n<p><img src=\"https://static.tigerbbs.com/b04ade705354c4825038c4dfcd0187d9\" tg-width=\"700\" tg-height=\"500\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Palantir Technologies: Implied downside of 12%</h3>\n<p>Since its direct listing in late September 2020, data-mining company <b>Palantir Technologies</b> (NYSE:PLTR) has been a favorite among growth and retail investors. But if Wall Street's <a href=\"https://laohu8.com/S/AONE\">one</a>-year consensus price target proves accurate, Palantir will head in reverse by up to 12%.</p>\n<p>The likeliest reason Wall Street is tempering expectations on Palantir is valuation. Specifically, Palantir ended June 17 with a market cap of nearly $48 billion, but is on track to bring in perhaps $1.5 billion in full-year sales in 2021. That's a multiple of about 32 times sales. Even if Palantir continues to grow its top-line at 30% annually, it could take years for this price-to-sales multiple to come down to anywhere close to the average for cloud stocks.</p>\n<p>Another possible concern is the growth potential for its government-focused Gotham platform. Big government contract wins in the U.S. have been primarily responsible for Palantir's exceptional growth rate. However, there remains an outside chance that President Joe Biden may curb funding to some of the federal agencies that employ Palantir's services.</p>\n<p>Over the long run, I'm optimistic and believe Palantir's platform is unlike anything else available. But tempering near-term expectations given its valuation premium may be warranted.</p>\n<p><img src=\"https://static.tigerbbs.com/a38605bee8e62f3e8aa414fa24278e7e\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Moderna: Implied downside of 11%</h3>\n<p>Biotech stock <b>Moderna</b> (NASDAQ:MRNA) is arguably the biggest beneficiary of the coronavirus disease 2019 (COVID-19) pandemic. It's <a href=\"https://laohu8.com/S/AONE.U\">one</a> of only three drugmakers to currently have their COVID-19 vaccine approved on an emergency-use authorization (EUA) basis in the United States. But if Wall Street's consensus 12-month price target is correct, it's stock is also on its way to a double-digit decline.</p>\n<p>Why the lack of love from Wall Street? The answer looks to be analysts looking to the future. While Moderna's COVID-19 vaccine is a mainstay in the U.S., and it's likely to play a clear role in other markets, time might prove the company's enemy. Over time, new vaccines are expected to come onto the scene, which'll eat away at Moderna's potential pool of patients.</p>\n<p>The other worry is that no one is exactly certain how long COVID-19 vaccine immunity will last. If it's a year, Moderna is unlikely to be the only drugmaker supplying booster shots. Meanwhile, if it's longer than a year, it means reduced sales opportunities for the company.</p>\n<p>Based solely on Wall Street's earnings per share consensus in 2021 and 2022, Moderna appears reasonably priced. But with the company staring down a potentially significant haircut in revenue next year as new drugmakers enter the space, caution is advised.</p>\n<p><img src=\"https://static.tigerbbs.com/07841e6a8173146a0fbfddf95a0f1ccb\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>GameStop: Implied downside of 71%</h3>\n<p>This will probably come as a shock to no one, but Reddit favorite <b>GameStop</b> (NYSE:GME) is fully expected to fall flat on its face. Even though Wall Street's consensus price target for the company has quintupled in recent months, it <i>still</i> implies up to 71% downside over the next year.</p>\n<p>The biggest issue for GameStop is that its valuation has completely detached from its underlying fundamentals. While it's not uncommon for stocks to trade on emotion for short periods of time, operating performance is what always dictates the long-term movement in the share price of a stock. When it comes to operating performance, GameStop has been a dud.</p>\n<p>Although the company's first-quarter fiscal results highlighted a 25% net sales increase from the prior-year period, total sales for the company have been falling precipitously for years. That's because video game retailer GameStop recognized the shift to digital gaming too late, and it's now stuck with its massive portfolio of brick-and-mortar gaming stores. Even though e-commerce sales have been a bright spot for the company, slashing costs and closing stores remains its No. 1 priority.</p>\n<p>With sufficient cash, bankruptcy isn't a concern for GameStop. But without any true top-line growth and the company still losing money, it's an impossible sell at its current price tag.</p>\n<p><img src=\"https://static.tigerbbs.com/c7ff785aa0040a5565d474390f58b47a\" tg-width=\"700\" tg-height=\"457\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Ocugen: Implied downside of 18%</h3>\n<p>Volatile clinical-stage biotech stock <b>Ocugen</b> (NASDAQ:OCGN) may also be in for an unpleasant next 12 months. The company behind an experimental COVID-19 vaccine (Covaxin) and a trio of internally developed eye-blindness candidates is expected to shed 18% of its value, if Wall Street's consensus price target is correct.</p>\n<p>Arguably the biggest issue for Ocugen is the clinical update the company issued on June 10 concerning Covaxin. Even though partner Bharat Biotech led a large clinical study in India that yielded an overall efficacy of 78%, along with 100% efficacy in preventing severe forms of COVID-19, Ocugen announced on June 10 that it would forgo seeking an EUA in the U.S. and would instead file for a biologics license application. In other words, Ocugen's path to a quick emergency approval in the U.S. just flew out the window.</p>\n<p>What's more, the U.S. Food and Drug Administration's requested additional information and data on Covaxin. This is a fancy of saying that Ocugen will very likely have to run a clinical study in the U.S. prior to submitting Covaxin for approval. That means added costs and an even longer wait before Ocugen has a chance to penetrate the lucrative U.S. market.</p>\n<p>Though it's impossible to predict how long COVID-19 vaccine immunity will last, Ocugen's chances of being a significant player in the U.S. COVID-19 vaccine space are dwindling.</p>\n<p><img src=\"https://static.tigerbbs.com/91f6037829ea3fb0ae1cae0b95d8d11e\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>NVIDIA: Implied downside of 3%</h3>\n<p>Don't adjust your computer, laptop, or smartphone screens -- that really says <b>NVIDIA</b> (NASDAQ:NVDA). Following its incredible run higher (NVIDIA has doubled over the past year), graphics processing unit giant NVIDIA closed 3% above Wall Street's consensus price target, as of June 17.</p>\n<p>One reason for tempered expectations at this point has to be valuation. Even with NVIDIA crushing expectations and seeing strong PC gaming demand, sales growth is expected to slow from an estimated 49% in fiscal 2022 to a high single digit percentage in each of the next two fiscal years. In fact, the company closed at nearly 20 times projected sales for the current fiscal year. That's a bit optimistic given an expected sales growth slowdown.</p>\n<p>Perhaps the other reason Wall Street expects NVIDIA to go sideways is the company's cryptocurrency mining chip segment. While sales of crypto chips could hit $400 million in the current quarter, demand is entirely dependent on the hype surrounding digital currencies and the favorability of technical charts. Crypto is just as well known for its long bear markets as it is for the big gains it's delivered over the past decade. If another lull strikes, a fast-growing ancillary segment for NVIDA could easily become a drag.</p>\n<p>For what it's worth, I see no fundamental reasons to sell NVIDIA if you're already a long-term shareholder. But if you're on the outside looking in, I don't exactly see $746 as an attractive entry point, either.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Ultra-Popular Stocks Wall Street Views as Overvalued</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Ultra-Popular Stocks Wall Street Views as Overvalued\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-21 21:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/21/5-ultra-popular-stocks-wall-street-view-overvalued/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Generally speaking, it pays to be bullish on Wall Street. Despite navigating its way through Black Monday in 1987, the dot-com bubble, the Great Recession, and more recently the coronavirus crash, the...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/21/5-ultra-popular-stocks-wall-street-view-overvalued/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc.","MRNA":"Moderna, Inc.","NVDA":"英伟达","OCGN":"Ocugen","GME":"游戏驿站"},"source_url":"https://www.fool.com/investing/2021/06/21/5-ultra-popular-stocks-wall-street-view-overvalued/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2145084835","content_text":"Generally speaking, it pays to be bullish on Wall Street. Despite navigating its way through Black Monday in 1987, the dot-com bubble, the Great Recession, and more recently the coronavirus crash, the average annual total return for the benchmark S&P 500 since 1980, including dividends, is north of 11%.\nNot surprisingly, we see this optimism readily apparent in Wall Street's ratings on stocks. According to FactSet, more than half of all stocks carry a consensus buy rating, 38% have the equivalent of a hold rating, and just 7% are rated as sells. Yet, history shows that far more than 7% of stocks will eventually head lower.\nBased on Wall Street's consensus price targets, the following five ultra-popular stocks are all expected to lose value over the coming 12 months.\n\nImage source: Getty Images.\nPalantir Technologies: Implied downside of 12%\nSince its direct listing in late September 2020, data-mining company Palantir Technologies (NYSE:PLTR) has been a favorite among growth and retail investors. But if Wall Street's one-year consensus price target proves accurate, Palantir will head in reverse by up to 12%.\nThe likeliest reason Wall Street is tempering expectations on Palantir is valuation. Specifically, Palantir ended June 17 with a market cap of nearly $48 billion, but is on track to bring in perhaps $1.5 billion in full-year sales in 2021. That's a multiple of about 32 times sales. Even if Palantir continues to grow its top-line at 30% annually, it could take years for this price-to-sales multiple to come down to anywhere close to the average for cloud stocks.\nAnother possible concern is the growth potential for its government-focused Gotham platform. Big government contract wins in the U.S. have been primarily responsible for Palantir's exceptional growth rate. However, there remains an outside chance that President Joe Biden may curb funding to some of the federal agencies that employ Palantir's services.\nOver the long run, I'm optimistic and believe Palantir's platform is unlike anything else available. But tempering near-term expectations given its valuation premium may be warranted.\n\nImage source: Getty Images.\nModerna: Implied downside of 11%\nBiotech stock Moderna (NASDAQ:MRNA) is arguably the biggest beneficiary of the coronavirus disease 2019 (COVID-19) pandemic. It's one of only three drugmakers to currently have their COVID-19 vaccine approved on an emergency-use authorization (EUA) basis in the United States. But if Wall Street's consensus 12-month price target is correct, it's stock is also on its way to a double-digit decline.\nWhy the lack of love from Wall Street? The answer looks to be analysts looking to the future. While Moderna's COVID-19 vaccine is a mainstay in the U.S., and it's likely to play a clear role in other markets, time might prove the company's enemy. Over time, new vaccines are expected to come onto the scene, which'll eat away at Moderna's potential pool of patients.\nThe other worry is that no one is exactly certain how long COVID-19 vaccine immunity will last. If it's a year, Moderna is unlikely to be the only drugmaker supplying booster shots. Meanwhile, if it's longer than a year, it means reduced sales opportunities for the company.\nBased solely on Wall Street's earnings per share consensus in 2021 and 2022, Moderna appears reasonably priced. But with the company staring down a potentially significant haircut in revenue next year as new drugmakers enter the space, caution is advised.\n\nImage source: Getty Images.\nGameStop: Implied downside of 71%\nThis will probably come as a shock to no one, but Reddit favorite GameStop (NYSE:GME) is fully expected to fall flat on its face. Even though Wall Street's consensus price target for the company has quintupled in recent months, it still implies up to 71% downside over the next year.\nThe biggest issue for GameStop is that its valuation has completely detached from its underlying fundamentals. While it's not uncommon for stocks to trade on emotion for short periods of time, operating performance is what always dictates the long-term movement in the share price of a stock. When it comes to operating performance, GameStop has been a dud.\nAlthough the company's first-quarter fiscal results highlighted a 25% net sales increase from the prior-year period, total sales for the company have been falling precipitously for years. That's because video game retailer GameStop recognized the shift to digital gaming too late, and it's now stuck with its massive portfolio of brick-and-mortar gaming stores. Even though e-commerce sales have been a bright spot for the company, slashing costs and closing stores remains its No. 1 priority.\nWith sufficient cash, bankruptcy isn't a concern for GameStop. But without any true top-line growth and the company still losing money, it's an impossible sell at its current price tag.\n\nImage source: Getty Images.\nOcugen: Implied downside of 18%\nVolatile clinical-stage biotech stock Ocugen (NASDAQ:OCGN) may also be in for an unpleasant next 12 months. The company behind an experimental COVID-19 vaccine (Covaxin) and a trio of internally developed eye-blindness candidates is expected to shed 18% of its value, if Wall Street's consensus price target is correct.\nArguably the biggest issue for Ocugen is the clinical update the company issued on June 10 concerning Covaxin. Even though partner Bharat Biotech led a large clinical study in India that yielded an overall efficacy of 78%, along with 100% efficacy in preventing severe forms of COVID-19, Ocugen announced on June 10 that it would forgo seeking an EUA in the U.S. and would instead file for a biologics license application. In other words, Ocugen's path to a quick emergency approval in the U.S. just flew out the window.\nWhat's more, the U.S. Food and Drug Administration's requested additional information and data on Covaxin. This is a fancy of saying that Ocugen will very likely have to run a clinical study in the U.S. prior to submitting Covaxin for approval. That means added costs and an even longer wait before Ocugen has a chance to penetrate the lucrative U.S. market.\nThough it's impossible to predict how long COVID-19 vaccine immunity will last, Ocugen's chances of being a significant player in the U.S. COVID-19 vaccine space are dwindling.\n\nImage source: Getty Images.\nNVIDIA: Implied downside of 3%\nDon't adjust your computer, laptop, or smartphone screens -- that really says NVIDIA (NASDAQ:NVDA). Following its incredible run higher (NVIDIA has doubled over the past year), graphics processing unit giant NVIDIA closed 3% above Wall Street's consensus price target, as of June 17.\nOne reason for tempered expectations at this point has to be valuation. Even with NVIDIA crushing expectations and seeing strong PC gaming demand, sales growth is expected to slow from an estimated 49% in fiscal 2022 to a high single digit percentage in each of the next two fiscal years. In fact, the company closed at nearly 20 times projected sales for the current fiscal year. That's a bit optimistic given an expected sales growth slowdown.\nPerhaps the other reason Wall Street expects NVIDIA to go sideways is the company's cryptocurrency mining chip segment. While sales of crypto chips could hit $400 million in the current quarter, demand is entirely dependent on the hype surrounding digital currencies and the favorability of technical charts. Crypto is just as well known for its long bear markets as it is for the big gains it's delivered over the past decade. If another lull strikes, a fast-growing ancillary segment for NVIDA could easily become a drag.\nFor what it's worth, I see no fundamental reasons to sell NVIDIA if you're already a long-term shareholder. But if you're on the outside looking in, I don't exactly see $746 as an attractive entry point, either.","news_type":1},"isVote":1,"tweetType":1,"viewCount":439,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":162305518,"gmtCreate":1624033327334,"gmtModify":1631893946610,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Good say. Oil is back","listText":"Good say. Oil is back","text":"Good say. Oil is back","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/162305518","repostId":"1138062216","repostType":4,"repost":{"id":"1138062216","pubTimestamp":1624029740,"share":"https://www.laohu8.com/m/news/1138062216?lang=&edition=full","pubTime":"2021-06-18 23:22","market":"us","language":"en","title":"Energy stocks roar toward their best year in three decades amid recovery in oil","url":"https://stock-news.laohu8.com/highlight/detail?id=1138062216","media":"cnbc","summary":"It’s six months into 2021, andenergy stocksare already on pace for their best year in more than thre","content":"<div>\n<p>It’s six months into 2021, andenergy stocksare already on pace for their best year in more than three decades, leading some to believe the run may be due for a pullback.\nThe group pulled back on ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/18/energy-stocks-roar-toward-their-best-year-in-three-decades-amid-recovery-in-oil.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Energy stocks roar toward their best year in three decades amid recovery in oil</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEnergy stocks roar toward their best year in three decades amid recovery in oil\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 23:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/18/energy-stocks-roar-toward-their-best-year-in-three-decades-amid-recovery-in-oil.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s six months into 2021, andenergy stocksare already on pace for their best year in more than three decades, leading some to believe the run may be due for a pullback.\nThe group pulled back on ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/18/energy-stocks-roar-toward-their-best-year-in-three-decades-amid-recovery-in-oil.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DVN":"德文能源","MRO":"马拉松石油","FANG":"Diamondback Energy","EOG":"依欧格资源"},"source_url":"https://www.cnbc.com/2021/06/18/energy-stocks-roar-toward-their-best-year-in-three-decades-amid-recovery-in-oil.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1138062216","content_text":"It’s six months into 2021, andenergy stocksare already on pace for their best year in more than three decades, leading some to believe the run may be due for a pullback.\nThe group pulled back on Thursday and Friday, but is still up more than 40% for the year. That’s almost double the 23% return for the real estate sector, which is the second-best sector. The S&P 500 is up nearly 12% this year.\nEnergy’s big start to the year means that even if the sector goes nowhere for the rest of 2021, it will still be the best year since 1990 by nearly 10%, according to Bay Crest Partners chief market technician Jonathan Krinsky.\nThe surge in energy stocks comes on the back of a recovery in oil prices, and as investors return to areas of the market that were left out of 2020′s rebound from the pandemic lows. The sector was also starting from a low base. In 2020, the group fell 37.3% for its worst performance since inception in 1989.\nKrinsky is among those saying the upside move is overdone, and his call is to sell crude oil and energy stocks broadly. From a technical standpoint, he noted that the $420 to $450 level acted as support — a floor — for the group during the last decade. But then during the Covid sell-off, the sector plunged below that key level — breaking below $200 — as the pandemic ground economies around the world to a halt.\n\nThe S&P Energy Sector has since recovered and traded as high as $420 on Thursday, inching closer to their prior support level, which now acts as resistance, or where an uptrend could be expected to reverse.\n“Oftentimes when you break a very important support like that, once you come back and test it as resistance, it’s difficult to exceed that — at least on the first try,” Krinsky noted.\nGauging performance from Jan. 1 might seem arbitrary, but he added that the sector’s outperformance is notable from virtually any date. Over the last eight months, the group has returned over 90%, which Krinsky says is more than two times the prior largest such gain over the last three decades.\n“Even on a rolling basis this is somewhat unprecedented,” he said. His bearish call on the sector also stems from other commodities breaking down, including lumber and copper. The latter is now breaking its uptrend, and Krinsky noted that copper was a leading indicator for the 2020 low, hitting a bottom one month ahead of West Texas Intermediate Crude futures.\nTOP-PERFORMING S&P 500 ENERGY STOCKS THIS YEAR\n\n\n\nTICKER\nCOMPANY\nPRICE\n%CHANGE\nYIELD\nPREVIOUS CLOSE\n\n\n\n\nMRO\nMarathon Oil Corp\n12.83\n-0.4655\n12.83\n12.89\n\n\nFANG\nDiamondback Energy Inc\n86.23\n-0.7596\n86.23\n86.89\n\n\nDVN\nDevon Energy Corp\n27.22\n-1.3411\n27.22\n27.59\n\n\nEOG\nEOG Resources Inc\n80.795\n-0.7798\n80.795\n81.43\n\n\n\nWithin the sector,Marathon Oilhas gained nearly 93% this year, making it the top-performing energy stock in the S&P 500.\nDiamondback Energyrose about 80% year to date, andDevon Energyclimbed more than 70%.OccidentalandEOG Resourcesare up more than 60%.\nAmid the outperformance the group remains unloved by Wall Street as factors – including environmental, social and corporate governance investing – prompt investors to shy away from the sector. Bank of America recently noted that the entire sector makes up just 2% of the average long-only portfolio, or less than half the allocation toward Facebook, which sits at 4.2%.\nEnergy still comprises a tiny portion of the S&P 500, but as the sector’s weighting grows, fund managers who shun the space could risk returns.\nMRB Partners on Thursday reiterated its overweight rating on the group, saying the recovery in demand for petroleum products, coupled with ongoing supply constraints, should push oil prices higher, leading to further returns for energy stocks.\n“Strengthening cash flows, leaner cost structures, and better capital discipline position the industry to moderately increase capital returns to shareholders,” strategists led by Salvatore Ruscitti wrote in a note to clients. “Relative performance will benefit from the reflationary backdrop and our expectations for a softer U.S. dollar.”\nWhen it comes to specific stocks, Gilman Hill Asset Management CEO Jenny Harrington owns names includingChevron,OneokandKinder Morgan. She noted on Thursday’s“Halftime Report”that it’s important to look at the whole picture. While oil is at its highest level in nearly two and a half years, it’s trading at about half the level it was just a few years ago. On the flip side, it’s well above where it traded in June of 2020 as the pandemic took hold.\n“They’re all trading at a fraction of the market multiple,” Harrington said of the energy stocks she owns. “They all have hefty dividend yields,” she added, arguing that strong earnings growth means “there’s a lot of room to go here.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":266,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166895084,"gmtCreate":1624000341948,"gmtModify":1631893946614,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Pls like and comment.&nbsp; Thanks","listText":"Pls like and comment.&nbsp; Thanks","text":"Pls like and comment. Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/166895084","repostId":"1149669763","repostType":4,"repost":{"id":"1149669763","pubTimestamp":1623995416,"share":"https://www.laohu8.com/m/news/1149669763?lang=&edition=full","pubTime":"2021-06-18 13:50","market":"us","language":"en","title":"Malaysia’s Carsome Weighs U.S. Listing With SPAC as Option","url":"https://stock-news.laohu8.com/highlight/detail?id=1149669763","media":"Bloomberg","summary":"Startup is seeking a valuation of about $2 billion in the deal\nKuala Lumpur-based Carsome set to be ","content":"<ul>\n <li>Startup is seeking a valuation of about $2 billion in the deal</li>\n <li>Kuala Lumpur-based Carsome set to be country’s first unicorn</li>\n</ul>\n<p>Carsome Sdn., an online used car platform in Southeast Asia, is weighing going public in the U.S. in a deal that would make it Malaysia’s first unicorn, according to people with knowledge of the matter.</p>\n<p>The startup is working with advisers and is seeking a valuation of about $2 billion in a listing, which could be a merger with a special purpose acquisition company or a conventional initial public offering, said the people. A deal to take the company public could take place as soon as the end of the year, they said.</p>\n<p>Kuala Lumpur-based Carsome is conducting a pre-IPO funding round that aims to raise about $150 million, said the people, asking not to be identified because the matter is private.</p>\n<p>Deliberations are ongoing and details of the listing could change, they said. A representative for Carsome didn’t immediately respond to requests for comment.</p>\n<p>At a $2 billion valuation, Carsome would become Malaysia’s first unicorn. The car sales platform operator would join other companies in the region such as Indonesia’s&nbsp;Tiket.com&nbsp;as well as Singapore’s&nbsp;PropertyGuru Pte&nbsp;and&nbsp;Grab Holdings Inc.&nbsp;in planning to list in the U.S. via mergers with blank-check firms.</p>\n<p>Carsome was founded in 2015 and has expanded its presence to Indonesia, Thailand and Singapore in recent years. The company’s platform sees sales involving more than 40,000 cars annually, with a transaction value of over $600 million, according to its&nbsp;website. It works with more than 8,000 used car dealers who have collectively made more than 2.3 million bids.</p>\n<p>Its regional rival, Singaporean used car platform Carro,raised$360 million in June to fuel expansion in Thailand and Indonesia before pursuing a U.S. listing.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Malaysia’s Carsome Weighs U.S. Listing With SPAC as Option</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMalaysia’s Carsome Weighs U.S. Listing With SPAC as Option\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 13:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-18/malaysia-s-carsome-said-to-mull-u-s-listing-with-spac-as-option><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Startup is seeking a valuation of about $2 billion in the deal\nKuala Lumpur-based Carsome set to be country’s first unicorn\n\nCarsome Sdn., an online used car platform in Southeast Asia, is weighing ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-18/malaysia-s-carsome-said-to-mull-u-s-listing-with-spac-as-option\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.bloomberg.com/news/articles/2021-06-18/malaysia-s-carsome-said-to-mull-u-s-listing-with-spac-as-option","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1149669763","content_text":"Startup is seeking a valuation of about $2 billion in the deal\nKuala Lumpur-based Carsome set to be country’s first unicorn\n\nCarsome Sdn., an online used car platform in Southeast Asia, is weighing going public in the U.S. in a deal that would make it Malaysia’s first unicorn, according to people with knowledge of the matter.\nThe startup is working with advisers and is seeking a valuation of about $2 billion in a listing, which could be a merger with a special purpose acquisition company or a conventional initial public offering, said the people. A deal to take the company public could take place as soon as the end of the year, they said.\nKuala Lumpur-based Carsome is conducting a pre-IPO funding round that aims to raise about $150 million, said the people, asking not to be identified because the matter is private.\nDeliberations are ongoing and details of the listing could change, they said. A representative for Carsome didn’t immediately respond to requests for comment.\nAt a $2 billion valuation, Carsome would become Malaysia’s first unicorn. The car sales platform operator would join other companies in the region such as Indonesia’s Tiket.com as well as Singapore’s PropertyGuru Pte and Grab Holdings Inc. in planning to list in the U.S. via mergers with blank-check firms.\nCarsome was founded in 2015 and has expanded its presence to Indonesia, Thailand and Singapore in recent years. The company’s platform sees sales involving more than 40,000 cars annually, with a transaction value of over $600 million, according to its website. It works with more than 8,000 used car dealers who have collectively made more than 2.3 million bids.\nIts regional rival, Singaporean used car platform Carro,raised$360 million in June to fuel expansion in Thailand and Indonesia before pursuing a U.S. listing.","news_type":1},"isVote":1,"tweetType":1,"viewCount":331,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":161037621,"gmtCreate":1623896069063,"gmtModify":1631893946617,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Like and comment pls. Thanks 😊","listText":"Like and comment pls. Thanks 😊","text":"Like and comment pls. Thanks 😊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/161037621","repostId":"2144130887","repostType":4,"isVote":1,"tweetType":1,"viewCount":308,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":185221565,"gmtCreate":1623654921057,"gmtModify":1631893946625,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Pls comment and like with many thanks","listText":"Pls comment and like with many thanks","text":"Pls comment and like with many thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/185221565","repostId":"1146430910","repostType":4,"isVote":1,"tweetType":1,"viewCount":312,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":185221809,"gmtCreate":1623654870901,"gmtModify":1631893946628,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/185221809","repostId":"1165811803","repostType":4,"repost":{"id":"1165811803","pubTimestamp":1623632712,"share":"https://www.laohu8.com/m/news/1165811803?lang=&edition=full","pubTime":"2021-06-14 09:05","market":"us","language":"en","title":"4 Unshortable Stocks That Are Too Risky to Bet Against","url":"https://stock-news.laohu8.com/highlight/detail?id=1165811803","media":"InvestorPlace","summary":"If you are thinking about shorting one of these companies, you're doing something wrong. The markets are dealing with an army of investors who are after heavily shorted stocks. But there are also fundamentally strong names where initiating a short position can be risky. These are the so called unshortable stocks.From a fundamental perspective, Nvidia has been on a high growth trajectory. For the first quarter of 2022, the company reported revenue growth of 84% to $5.66 billion. Growth was health","content":"<p>If you are thinking about shorting one of these companies, you're doing something wrong</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/203e343ee38d5c182697edcd4932e483\" tg-width=\"1024\" tg-height=\"576\"><span>Source: Vladeep / Shutterstock.com</span></p>\n<p>The markets are dealing with an army of investors who are after heavily shorted stocks. But there are also fundamentally strong names where initiating a short position can be risky. These are the so called unshortable stocks.</p>\n<p>True,&nbsp;Short squeeze rallies have delivered multi-fold returns for investors.<b>AMC Entertainment</b>(NYSE:<b><u>AMC</u></b>) is the recent case of a short squeeze rally. However, this does not change the fact that some stocks are worth going short. It’s very likely that AMC stock will witness an equally sharp correction.</p>\n<p>That’s not the case with unshortable stocks.</p>\n<p>My focus is on four unshortable stocks where short interest as a percentage of free float is approximately 1%. Two of these stocks trade near all-time highs. The other two are in a consolidation mode and there seems to be a high probability of a breakout on the upside.</p>\n<p>The reasons for these stocks being unshortable are strong fundamentals, high growth and strong cash flows. Additionally, there are ample positive business growth catalysts on the horizon.</p>\n<p>Let’s take a deeper look into the reasons that make these stocks unshortable.</p>\n<ul>\n <li><b>Nvidia</b>(NASDAQ:<b><u>NVDA</u></b>)</li>\n <li><b>Target</b>(NYSE:<b><u>TGT</u></b>)</li>\n <li><b>Shopify</b>(NYSE:<b><u>SHOP</u></b>)</li>\n <li><b>Apple</b>(NASDAQ:<b><u>AAPL</u></b>)</li>\n</ul>\n<p><b>Nvidia (NVDA)</b></p>\n<p>NVDA stock is currently trading near 52-week highs. However, the short interest in the stock is just 1% of the free float. This is probably an indication of the point that NVDA stock is among the unshortable stocks.</p>\n<p>From a fundamental perspective, Nvidia has been on a high growth trajectory. For the first quarter of 2022, the company reported revenue growth of 84% to $5.66 billion. Growth was healthy in the gaming as well as data center segment.</p>\n<p>In addition, Nvidia reported&nbsp;operating cash flow of $1.9 billion for the quarter. This would imply an annualized operating cash flow of nearly $8 billion. The company has high financial flexibility to invest in innovation and pursue inorganic growth.</p>\n<p>In a recent news, Nvidia has asked&nbsp;Chinese regulators to approve the $40 billion acquisition&nbsp;of&nbsp;<b>Arm</b>. A possible approval in the coming quarters will ensure that the stock momentum remains positive.</p>\n<p>With focus on artificial intelligence, Nvidia has also made inroads in multiple industries. This includes AI chips and solutions for robotics, self-driving and healthcare, among others. Therefore, with multiple growth catalysts, NVDA stock remains attractive.</p>\n<p><b>Target (TGT)</b></p>\n<p>TGT stock is another name that I would include among unshortable stocks. The stock trades near all-time highs and looks good for further upside.</p>\n<p>UBS analyst Michael Lasser sees Target as “structurally improved as its strong positioning&nbsp;becomes even clearer in upcoming quarters.” Lasser has a price target of $265 for the stock.</p>\n<p>As the U.S. economy witnesses wider reopening, Target is positioned to benefit. According to Moody’s Analytics, Americans were holding&nbsp;$2.6 trillion in excess savings as of mid-April. The possibility of a post-pandemic consumption boom is likely to be good news for Target, among other retailers.</p>\n<p>Target has already been delivering stellar growth. For the first quarter, the company&nbsp;reported comparable sales growth of 22.9%&nbsp;on a year-on-year basis. Digital comparable sales growth was 50%.</p>\n<p>Clearly, Target is emerging from the pandemic with superior omni-channel capabilities. Initiatives such as order pick-up, drive-up and same-day shipment services are likely to ensure that comparable sales growth remains strong.</p>\n<p>From a financial perspective, Target reported cash flows of $1.1 billion for the quarter. With more than $4 billion in annualized cash flow visibility, dividend and share repurchase will continue.</p>\n<p>Overall, TGT stock looks attractive considering the growth momentum. With an impending spending boom, it might be best to avoid shorting the stock.</p>\n<p><b>Shopify (SHOP)</b></p>\n<p>SHOP stock seems to be trading at premium valuations. However, the stock has consolidated in the broad range of $1,000 to $1,200. Short interest is low and considering the company’s growth outlook, the stock is among the top unshortable stocks.</p>\n<p>For the first quarter, Shopify reported revenue growth of 110% on a year-over-year basis to $988.6 million. An important point to note is that&nbsp;monthly recurring revenue accelerated by 62% to $89.9 million. With sustained growth in monthly recurring revenue, the company is positioned for robust long-term cash flows.</p>\n<p>With the pandemic, e-commerce growth has accelerated globally. Shopify is likely to benefit from positive tailwinds in the coming years. It’s also worth noting that the company has&nbsp;expanded offerings for merchants. This includes Shopify Capital, Shopify Shipping and Shopify Plus. As merchants scale up, there is ample scope for revenue growth.</p>\n<p>As of March, Shopify reported $7.87 billion in cash and equivalents. As the company expands globally, there is ample financial flexibility to invest in platform upgrade and new merchant solutions. As an example, the company recently introduced Shopify POS offering to merchants.</p>\n<p>Overall, SHOP stock looks attractive with strong top-line growth and clear visibility for robust cash flows in the long-term.</p>\n<p><b>Apple (AAPL)</b></p>\n<p>AAPL stock is another name that too risky to bet against. The company has always surprised investors and it seems that the stock is positioned for a breakout after the current consolidation. With strong growth and a production innovation pipeline, it’s not surprising that short interest in AAPL stock is less than 1% of the free float.</p>\n<p>As I write,<i>Reuters</i>&nbsp;reports that Apple is in&nbsp;talks with Chinese manufacturers for a car battery factory&nbsp;in the U.S. The company seems to be gradually working towards its first electric vehicle. That’s likely to keep the markets excited.</p>\n<p>Apple has also witnessed&nbsp;strong growth in the wearables and services segment. Besides strong top-line growth, revenue is more diversified. At the same time, iPhone sales are likely to remain robust with 5G being a key growth driver.</p>\n<p>Apple’s cash glut also implies sustained value creation through share repurchase and possibly higher dividends. Of course, the cash buffer gives the company ample headroom to invest in product innovation and possible acquisitions.</p>\n<p>Overall, as strong growth sustains, it’s too risky to short AAPL stock. On the contrary, current levels look attractive for considering some long-term exposure.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 Unshortable Stocks That Are Too Risky to Bet Against</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 Unshortable Stocks That Are Too Risky to Bet Against\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-14 09:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/4-unshortable-stocks-that-are-too-risky-to-bet-against/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you are thinking about shorting one of these companies, you're doing something wrong\nSource: Vladeep / Shutterstock.com\nThe markets are dealing with an army of investors who are after heavily ...</p>\n\n<a href=\"https://investorplace.com/2021/06/4-unshortable-stocks-that-are-too-risky-to-bet-against/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SHOP":"Shopify Inc","TGT":"塔吉特","NVDA":"英伟达","AAPL":"苹果"},"source_url":"https://investorplace.com/2021/06/4-unshortable-stocks-that-are-too-risky-to-bet-against/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165811803","content_text":"If you are thinking about shorting one of these companies, you're doing something wrong\nSource: Vladeep / Shutterstock.com\nThe markets are dealing with an army of investors who are after heavily shorted stocks. But there are also fundamentally strong names where initiating a short position can be risky. These are the so called unshortable stocks.\nTrue, Short squeeze rallies have delivered multi-fold returns for investors.AMC Entertainment(NYSE:AMC) is the recent case of a short squeeze rally. However, this does not change the fact that some stocks are worth going short. It’s very likely that AMC stock will witness an equally sharp correction.\nThat’s not the case with unshortable stocks.\nMy focus is on four unshortable stocks where short interest as a percentage of free float is approximately 1%. Two of these stocks trade near all-time highs. The other two are in a consolidation mode and there seems to be a high probability of a breakout on the upside.\nThe reasons for these stocks being unshortable are strong fundamentals, high growth and strong cash flows. Additionally, there are ample positive business growth catalysts on the horizon.\nLet’s take a deeper look into the reasons that make these stocks unshortable.\n\nNvidia(NASDAQ:NVDA)\nTarget(NYSE:TGT)\nShopify(NYSE:SHOP)\nApple(NASDAQ:AAPL)\n\nNvidia (NVDA)\nNVDA stock is currently trading near 52-week highs. However, the short interest in the stock is just 1% of the free float. This is probably an indication of the point that NVDA stock is among the unshortable stocks.\nFrom a fundamental perspective, Nvidia has been on a high growth trajectory. For the first quarter of 2022, the company reported revenue growth of 84% to $5.66 billion. Growth was healthy in the gaming as well as data center segment.\nIn addition, Nvidia reported operating cash flow of $1.9 billion for the quarter. This would imply an annualized operating cash flow of nearly $8 billion. The company has high financial flexibility to invest in innovation and pursue inorganic growth.\nIn a recent news, Nvidia has asked Chinese regulators to approve the $40 billion acquisition of Arm. A possible approval in the coming quarters will ensure that the stock momentum remains positive.\nWith focus on artificial intelligence, Nvidia has also made inroads in multiple industries. This includes AI chips and solutions for robotics, self-driving and healthcare, among others. Therefore, with multiple growth catalysts, NVDA stock remains attractive.\nTarget (TGT)\nTGT stock is another name that I would include among unshortable stocks. The stock trades near all-time highs and looks good for further upside.\nUBS analyst Michael Lasser sees Target as “structurally improved as its strong positioning becomes even clearer in upcoming quarters.” Lasser has a price target of $265 for the stock.\nAs the U.S. economy witnesses wider reopening, Target is positioned to benefit. According to Moody’s Analytics, Americans were holding $2.6 trillion in excess savings as of mid-April. The possibility of a post-pandemic consumption boom is likely to be good news for Target, among other retailers.\nTarget has already been delivering stellar growth. For the first quarter, the company reported comparable sales growth of 22.9% on a year-on-year basis. Digital comparable sales growth was 50%.\nClearly, Target is emerging from the pandemic with superior omni-channel capabilities. Initiatives such as order pick-up, drive-up and same-day shipment services are likely to ensure that comparable sales growth remains strong.\nFrom a financial perspective, Target reported cash flows of $1.1 billion for the quarter. With more than $4 billion in annualized cash flow visibility, dividend and share repurchase will continue.\nOverall, TGT stock looks attractive considering the growth momentum. With an impending spending boom, it might be best to avoid shorting the stock.\nShopify (SHOP)\nSHOP stock seems to be trading at premium valuations. However, the stock has consolidated in the broad range of $1,000 to $1,200. Short interest is low and considering the company’s growth outlook, the stock is among the top unshortable stocks.\nFor the first quarter, Shopify reported revenue growth of 110% on a year-over-year basis to $988.6 million. An important point to note is that monthly recurring revenue accelerated by 62% to $89.9 million. With sustained growth in monthly recurring revenue, the company is positioned for robust long-term cash flows.\nWith the pandemic, e-commerce growth has accelerated globally. Shopify is likely to benefit from positive tailwinds in the coming years. It’s also worth noting that the company has expanded offerings for merchants. This includes Shopify Capital, Shopify Shipping and Shopify Plus. As merchants scale up, there is ample scope for revenue growth.\nAs of March, Shopify reported $7.87 billion in cash and equivalents. As the company expands globally, there is ample financial flexibility to invest in platform upgrade and new merchant solutions. As an example, the company recently introduced Shopify POS offering to merchants.\nOverall, SHOP stock looks attractive with strong top-line growth and clear visibility for robust cash flows in the long-term.\nApple (AAPL)\nAAPL stock is another name that too risky to bet against. The company has always surprised investors and it seems that the stock is positioned for a breakout after the current consolidation. With strong growth and a production innovation pipeline, it’s not surprising that short interest in AAPL stock is less than 1% of the free float.\nAs I write,Reuters reports that Apple is in talks with Chinese manufacturers for a car battery factory in the U.S. The company seems to be gradually working towards its first electric vehicle. That’s likely to keep the markets excited.\nApple has also witnessed strong growth in the wearables and services segment. Besides strong top-line growth, revenue is more diversified. At the same time, iPhone sales are likely to remain robust with 5G being a key growth driver.\nApple’s cash glut also implies sustained value creation through share repurchase and possibly higher dividends. Of course, the cash buffer gives the company ample headroom to invest in product innovation and possible acquisitions.\nOverall, as strong growth sustains, it’s too risky to short AAPL stock. On the contrary, current levels look attractive for considering some long-term exposure.","news_type":1},"isVote":1,"tweetType":1,"viewCount":141,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":188293635,"gmtCreate":1623441824927,"gmtModify":1634033168950,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/188293635","repostId":"2142572209","repostType":4,"isVote":1,"tweetType":1,"viewCount":107,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183267572,"gmtCreate":1623333288296,"gmtModify":1634034477873,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Zhun bo","listText":"Zhun bo","text":"Zhun bo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/183267572","repostId":"1128810191","repostType":4,"isVote":1,"tweetType":1,"viewCount":40,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":180098584,"gmtCreate":1623163289348,"gmtModify":1634036257334,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Sad case for me&nbsp;","listText":"Sad case for me&nbsp;","text":"Sad case for me","images":[{"img":"https://static.tigerbbs.com/ddfa3fdd2e235373a5b97424619bef67","width":"1080","height":"2679"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/180098584","isVote":1,"tweetType":1,"viewCount":64,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":117542129,"gmtCreate":1623154023161,"gmtModify":1634036405390,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Please like and comment for me","listText":"Please like and comment for me","text":"Please like and comment for me","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/117542129","repostId":"1154765176","repostType":4,"repost":{"id":"1154765176","pubTimestamp":1623145510,"share":"https://www.laohu8.com/m/news/1154765176?lang=&edition=full","pubTime":"2021-06-08 17:45","market":"us","language":"en","title":"Amazon Stock: Has It Produced The Most Alpha In Big Tech?","url":"https://stock-news.laohu8.com/highlight/detail?id=1154765176","media":"The Street","summary":"A long-term investment in Amazon stock has historically produced outsized returns. But has AMZN been the best Big Tech player at producing alpha?The Amazon Maven faces off six mega-cap stocks.A few days ago, the Amazon Maven explained howa mere $100 monthly investment in Amazon stock  -Get Report since the company’s 1997 IPO would have led to riches: $2.7 million today. It is hard to imagine a methodical, long-term investment having performed as well as this one.But has AMZN shares created the m","content":"<blockquote><b>A long-term investment in Amazon stock has historically produced outsized returns. But has AMZN been the best Big Tech player at producing alpha? The Amazon Maven faces off six mega-cap stocks.</b></blockquote><p>A&nbsp;few days ago, the Amazon Maven explained howa mere $100 monthly investment in Amazon stock&nbsp;(<b>AMZN</b>) -Get Report&nbsp;since the company’s 1997 IPO would have led to riches: $2.7 million today. It is hard to imagine a methodical, long-term investment having performed as well as this one.</p><p>But has AMZN shares created the most alpha within the mega-cap tech universe? Could investors have done much better by betting on names like Apple&nbsp;(<b>AAPL</b>) or Microsoft&nbsp;(<b>MSFT</b>) instead?</p><p><b>What is alpha?</b></p><p>First, it helps to look closer at the concept of alpha. Generally, alpha is thought to be the returns that an investor can earn in excess of a benchmark. In other words: how much has a stock or portfolio risen relative to the S&amp;P 500 or the Nasdaq? Investopediasummarizesas follows:</p><blockquote>Alpha (α) is a term used in investing to describe an investment strategy's ability to beat the market, or its ‘edge’. Alpha is also referred to as ‘excess return’ or ‘abnormal rate of return’.</blockquote><p>To me, this is a good start. But alpha should also consider one crucial factor: risk.</p><p>Beating the S&amp;P 500 might simply mean higher sensitivity to market forces (i.e. beta). So, the better question is: how much return can a stock produce<b><i>relative to risk</i></b>. I believe that this is a more complete view of alpha.</p><p><b>Amazon stock vs. the rest</b></p><p>Considering absolute returns only, Amazon stock ranks remarkably high within Big Tech for historical share price performance. The chart below shows that, over the past 10 years, AMZN has only lagged Tesla (TSLA) in annualized gains.</p><p><img src=\"https://static.tigerbbs.com/8474b2c893b04f99bbc62cbf3aaa9bec\" tg-width=\"683\" tg-height=\"409\" referrerpolicy=\"no-referrer\">Now, let me introduce risk to the equation. Risk is often defined (maybe too simplistically) as volatility. The more a stock rises and falls from minute to minute, or day to day, or week to week, the riskier it is.</p><p>So, one way to assess a stock’s returns relative to risk, thus giving us a better idea of its alpha potential, is to divide annualized returns by annualized volatility. By this methodology, Amazon stock loses its silver medal to Microsoft.</p><p><img src=\"https://static.tigerbbs.com/760869278d2e71f120fe4f1fc108de5a\" tg-width=\"680\" tg-height=\"405\" referrerpolicy=\"no-referrer\">One takeaway here is that, over the past decade, Amazon has achieved higher returns than any other FAAMG stock, but not without exposing investors to more volatility. If history repeats, investors should expect high returns to come alongside relatively sharper ups and downs as well.</p><p>Another way to think about risk, one that I have favored recently, is to think about sizable losses. A good question to ask would be: how much has a stock produced in average annual returns relative to its worst trailing 12-month (TTM) performance?</p><p>Using this methodology, not only does Amazon stock lose its silver medal, but it also drops out of the podium altogether. See chart below, and notice that Facebook has also performed better than Amazon in the past ten years in loss-adjusted terms.</p><p><img src=\"https://static.tigerbbs.com/affd59dcb14135f4a2cc892ad143ec26\" tg-width=\"683\" tg-height=\"405\" referrerpolicy=\"no-referrer\">Figure 4: Ratio: Annualized return vs. Worst TTM return.</p><p>DM Martins Research</p><p>Amazon, in fact, has one of the worst track records within Big Tech when it comes to sharp losses. By November 2008, AMZN had seen 57% of its value evaporate over the previous year. Only Alphabet, around the same time, performed any worse than this.</p><p><b>The key takeaways for investors</b></p><p>Having said the above, I think that Amazon investors can learn a few lessons from this historical price action analysis:</p><ul><li>Amazon has been a high-performing name, both since the IPO and over the past decade. In absolute terms, it is hard to find many stocks that have consistently delivered outsized returns.</li><li>Once risk is introduced to the discussion, Amazon stock’s performance goes from “outstanding” to a less exhilarating “solid”. Peers like Tesla, Microsoft and even Facebook seem to have been better alpha producers. In the 10 years that preceded the pandemic, in fact, Amazon’s volatility-adjusted returns were about the same as the S&amp;P 500’s.</li><li>AMZN investors should understand that the stock could continue to produce outsized gains, but also endure higher volatility and sharper losses, as it has in the last decade or more.</li><li>As always, past performance is not a guarantee of future results. Use history as a rough guide to set expectations, but understand that share price behavior can be quite different going forward.</li></ul><p><b>Twitter speaks</b></p><p>Pop quiz: relative to volatility (that is, in risk-adjusted terms), which of the following mega-cap tech stock has delivered the best returns in the past 10 year? Leave your vote below and follow The Amazon Maven on Twitter!</p><p><img src=\"https://static.tigerbbs.com/e679074ff1db7d9f81416239eecca1dd\" tg-width=\"584\" tg-height=\"448\" referrerpolicy=\"no-referrer\"></p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amazon Stock: Has It Produced The Most Alpha In Big Tech?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmazon Stock: Has It Produced The Most Alpha In Big Tech?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 17:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/amazon/stock/amazon-stock-has-it-produced-the-most-alpha-in-big-tech><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>A long-term investment in Amazon stock has historically produced outsized returns. But has AMZN been the best Big Tech player at producing alpha? The Amazon Maven faces off six mega-cap stocks.A few ...</p>\n\n<a href=\"https://www.thestreet.com/amazon/stock/amazon-stock-has-it-produced-the-most-alpha-in-big-tech\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊"},"source_url":"https://www.thestreet.com/amazon/stock/amazon-stock-has-it-produced-the-most-alpha-in-big-tech","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154765176","content_text":"A long-term investment in Amazon stock has historically produced outsized returns. But has AMZN been the best Big Tech player at producing alpha? The Amazon Maven faces off six mega-cap stocks.A few days ago, the Amazon Maven explained howa mere $100 monthly investment in Amazon stock (AMZN) -Get Report since the company’s 1997 IPO would have led to riches: $2.7 million today. It is hard to imagine a methodical, long-term investment having performed as well as this one.But has AMZN shares created the most alpha within the mega-cap tech universe? Could investors have done much better by betting on names like Apple (AAPL) or Microsoft (MSFT) instead?What is alpha?First, it helps to look closer at the concept of alpha. Generally, alpha is thought to be the returns that an investor can earn in excess of a benchmark. In other words: how much has a stock or portfolio risen relative to the S&P 500 or the Nasdaq? Investopediasummarizesas follows:Alpha (α) is a term used in investing to describe an investment strategy's ability to beat the market, or its ‘edge’. Alpha is also referred to as ‘excess return’ or ‘abnormal rate of return’.To me, this is a good start. But alpha should also consider one crucial factor: risk.Beating the S&P 500 might simply mean higher sensitivity to market forces (i.e. beta). So, the better question is: how much return can a stock producerelative to risk. I believe that this is a more complete view of alpha.Amazon stock vs. the restConsidering absolute returns only, Amazon stock ranks remarkably high within Big Tech for historical share price performance. The chart below shows that, over the past 10 years, AMZN has only lagged Tesla (TSLA) in annualized gains.Now, let me introduce risk to the equation. Risk is often defined (maybe too simplistically) as volatility. The more a stock rises and falls from minute to minute, or day to day, or week to week, the riskier it is.So, one way to assess a stock’s returns relative to risk, thus giving us a better idea of its alpha potential, is to divide annualized returns by annualized volatility. By this methodology, Amazon stock loses its silver medal to Microsoft.One takeaway here is that, over the past decade, Amazon has achieved higher returns than any other FAAMG stock, but not without exposing investors to more volatility. If history repeats, investors should expect high returns to come alongside relatively sharper ups and downs as well.Another way to think about risk, one that I have favored recently, is to think about sizable losses. A good question to ask would be: how much has a stock produced in average annual returns relative to its worst trailing 12-month (TTM) performance?Using this methodology, not only does Amazon stock lose its silver medal, but it also drops out of the podium altogether. See chart below, and notice that Facebook has also performed better than Amazon in the past ten years in loss-adjusted terms.Figure 4: Ratio: Annualized return vs. Worst TTM return.DM Martins ResearchAmazon, in fact, has one of the worst track records within Big Tech when it comes to sharp losses. By November 2008, AMZN had seen 57% of its value evaporate over the previous year. Only Alphabet, around the same time, performed any worse than this.The key takeaways for investorsHaving said the above, I think that Amazon investors can learn a few lessons from this historical price action analysis:Amazon has been a high-performing name, both since the IPO and over the past decade. In absolute terms, it is hard to find many stocks that have consistently delivered outsized returns.Once risk is introduced to the discussion, Amazon stock’s performance goes from “outstanding” to a less exhilarating “solid”. Peers like Tesla, Microsoft and even Facebook seem to have been better alpha producers. In the 10 years that preceded the pandemic, in fact, Amazon’s volatility-adjusted returns were about the same as the S&P 500’s.AMZN investors should understand that the stock could continue to produce outsized gains, but also endure higher volatility and sharper losses, as it has in the last decade or more.As always, past performance is not a guarantee of future results. Use history as a rough guide to set expectations, but understand that share price behavior can be quite different going forward.Twitter speaksPop quiz: relative to volatility (that is, in risk-adjusted terms), which of the following mega-cap tech stock has delivered the best returns in the past 10 year? Leave your vote below and follow The Amazon Maven on Twitter!","news_type":1},"isVote":1,"tweetType":1,"viewCount":136,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":117546144,"gmtCreate":1623153945988,"gmtModify":1634036405977,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Yeah!!","listText":"Yeah!!","text":"Yeah!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/117546144","repostId":"1111940861","repostType":4,"isVote":1,"tweetType":1,"viewCount":134,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":117543634,"gmtCreate":1623153771328,"gmtModify":1634036407976,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/117543634","repostId":"1127979401","repostType":4,"repost":{"id":"1127979401","pubTimestamp":1623153568,"share":"https://www.laohu8.com/m/news/1127979401?lang=&edition=full","pubTime":"2021-06-08 19:59","market":"us","language":"en","title":"Opinion: Only ‘greedy’ drug companies will cure Alzheimer’s","url":"https://stock-news.laohu8.com/highlight/detail?id=1127979401","media":"marketwatch","summary":"Here’s a question for everyone in Congress and the White House, the federal bureaucracy, and all my ","content":"<p><img src=\"https://static.tigerbbs.com/783580e857537ceb68ca7c6330ee4132\" tg-width=\"1260\" tg-height=\"736\">Here’s a question for everyone in Congress and the White House, the federal bureaucracy, and all my fellow members of the (ahem) “mainstream media.”</p>\n<p>Now that BiogenBIIB,+38.34%has got approval forits new Alzheimer’s drug—the first approved by the FDA in almost 20 years — how much should they be allowed to charge for it?</p>\n<p>What’s the ethically correct figure? What will exempt them from charges of “greed” or “gouging?” What is “too much?”</p>\n<p>The manufacturing cost per pill? The cost plus a small margin? What’s the number?</p>\n<p>I bring this up because few things matter as much for the lives of senior citizens in America—and seniors in the rest of the world—than the development of new drugs. I have personally seen up close how Alzheimer’s destroys people, sometimes as young as their 50s and 60s. This has included close members of my family.</p>\n<p>Some six million Americans already have this cruel, vicious and incurable disease, and ahorrific 50 million around the world. That’s 50 million death sentences. Ten million more get it every year.</p>\n<p>The drug industry developed five vaccines in one year for COVID-19, a disease associated with the deaths of 3.7 million people world-wide. Alzheimer’s treatments? Oh, one for every 20 years.</p>\n<p>Let’s be honest: Many people subconsciously shrug off this issue on the principle that Alzheimer’s will only happen to someone else. Alas, many of the people reading this article are going to get this disease. For many more, your father, mother, wife or husband will get it. Or a sibling or close friend. At which point, the “hey, maybe we should have made this a bigger national priority” argument will strike, but too late to help.</p>\n<p>This is the context worth bearing in mind when we hear about drugs getting approved—and, just as importantly, when we hear people demagoguing about “greedy” drug companies and “overpriced” drugs. It’s not just this new Alzheimer’s drug, either.</p>\n<p>If “drug” companies are making out like bandits, someone really has to explain to me why it doesn’t show up in the…er…stock prices. In the past decade, investors the iShares U.S. Pharmaceuticals exchange-traded fundIHE,+0.61%have made far lower returns than they could have done just by randomly picking a bunch of non-pharmaceutical stocks out of the newspaper. These companies have been worse investments than a simple S&amp;P 500SPX,-0.08%index fund like the SPDR S&amp;P 500 ETFSPY,-0.10%,or the Invesco S&amp;P 500 Equal Weight ETFRSP,-0.18%.</p>\n<p>Even Biogen itself had substantially underperformed the broader stock market index for a decade. Until Monday.</p>\n<p>No, the industry returns aren’t terrible. But they are hardly the giant free oil well that critics sometimes suggest. I checked out the data from Dartmouth College finance professor Kenneth French, who has tracked stock market returns by industry going back decades. Going all the way back to the 1920s, according to his numbers, the pharmaceuticals industry barely cracks the top one-third of all industries by stock returns. So far this millennium, the total returns from major pharmaceutical companies have been about a third less than those from the S&amp;P 500 index. Biotechs have done much better, but they were a much smaller sector. And even biotech has trailed the returns of alcohol and tobacco companies.</p>\n<p>How are we going to get billions of dollars more capital invested in curing Alzheimer’s and diabetes and cancer when investors can make more money investing in making booze and cigarettes? This is upside down.</p>\n<p>Meanwhile the regulation are all messed up and back to front as well.This headline says it all: “FDA Approves Alzheimer’s Drug Despite Fierce Debate Over&nbsp;Whether&nbsp;It Works.”</p>\n<p>This is nuts. Maybe the new treatment makes things better, maybe it doesn’t. Apparently people aren’t certain. It’s hardly a surprise: The treatment is new, and the disease is complicated. But the first question to ask isn’t whether it makes things better, but whether it makes things worse. The current situation is catastrophic for anyone with the disease. People are dying. Lives are being destroyed.</p>\n<p>Waiting to be sure treatment works would be like falling out of a plane with a parachute on, but hesitating to pull the cord because, well, it might not work. It suggests a basic misunderstanding of game theory. (Or common sense.)</p>\n<p>It’s one thing to hesitate about approving a new drug for a nonfatal illness. You don’t want to make people sicker, or cause needless suffering or death. But with this kind of illness that really doesn’t apply.</p>\n<p>Anyone who says “oh, no, we need to be really careful, and if need be delay these new treatments for years to make sure they are absolutely 100% safe” is speaking from a position of privilege. They should try saying that to someone watching a loved one be destroyed by the illness. It’s easy to play that card when it’s not happening to you, or someone you love.</p>\n<p>A look through the Biogen’s public filings tells the sorry story. This new&nbsp;Alzheimer’s&nbsp;treatment entered Phase 3 trials in 2015—six years ago. Did I mention it took one year to get COVID vaccines to market?</p>\n<p>Meanwhile, check out all the costs associated with developing this treatment. Biogen struck a collaboration deal with Eisai to work on this drug in 2014. Since then the two of them have spent a total of $1.1 billion on it. If it hadn’t been approved, that’s $1.1 billion down the drain.</p>\n<p>I want more of these treatments. And I want them quickly, not every two decades. I want trillions pouring into this industry. And I know that lower returns, and more bureaucracy, aren’t the way to get them.</p>\n<p>None of this, of course, means blind, passive or foolish naiveté about the drug industry or pricing. Drug manufacturers spend about $160 million a year on lobbying, and people involved in the business donated nearly $30 million a year to politicians running for office. Look through the proxy statements and you’ll see plenty of Big Pharma CEOs living off<i>the fatta the lan</i>(like lots of other CEOs).Yes, of course Medicare should have greater freedom to negotiate drug prices.</p>\n<p>Few people know more about malfeasance and greed in the drug industry than investigative journalist Gerald Posner, who literally wrote the book on it —Pharma: Greed, Lies, and the Poisoning Of America.</p>\n<p>“Most of the time I agree with your take,” he tells me. “FDA red tape bureaucracy is slow and costly and good R&amp;D can cost a fortune, all with no guarantee of success. So risk takers, i.e. drug companies, should be rewarded with financial incentives.”</p>\n<p>But, he adds, U.S. drug companies are already getting plenty of help. The U.S. has the longest patent protections of any major economy. He adds that big U.S. pharma companies get huge research support from taxpayers through the National Institute for Health.</p>\n<p>“From 2010 through 2016, every one of the 210 drugs approved for sale by the FDA were completely or in part funded by the NIH,” he says. The fund came to more than $100 billion, he adds.</p>\n<p>All good points. But I fear that as long as it’s more profitable to invest in cigarettes or booze than it is in curing Alzheimer’s, we will all be left with Plan B for our old age: Hoping and praying we don’t get Alzheimer’s.</p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Opinion: Only ‘greedy’ drug companies will cure Alzheimer’s</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOpinion: Only ‘greedy’ drug companies will cure Alzheimer’s\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 19:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/only-greedy-drug-companies-will-cure-alzheimers-11623152892?mod=newsviewer_click><strong>marketwatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Here’s a question for everyone in Congress and the White House, the federal bureaucracy, and all my fellow members of the (ahem) “mainstream media.”\nNow that BiogenBIIB,+38.34%has got approval forits ...</p>\n\n<a href=\"https://www.marketwatch.com/story/only-greedy-drug-companies-will-cure-alzheimers-11623152892?mod=newsviewer_click\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.marketwatch.com/story/only-greedy-drug-companies-will-cure-alzheimers-11623152892?mod=newsviewer_click","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1127979401","content_text":"Here’s a question for everyone in Congress and the White House, the federal bureaucracy, and all my fellow members of the (ahem) “mainstream media.”\nNow that BiogenBIIB,+38.34%has got approval forits new Alzheimer’s drug—the first approved by the FDA in almost 20 years — how much should they be allowed to charge for it?\nWhat’s the ethically correct figure? What will exempt them from charges of “greed” or “gouging?” What is “too much?”\nThe manufacturing cost per pill? The cost plus a small margin? What’s the number?\nI bring this up because few things matter as much for the lives of senior citizens in America—and seniors in the rest of the world—than the development of new drugs. I have personally seen up close how Alzheimer’s destroys people, sometimes as young as their 50s and 60s. This has included close members of my family.\nSome six million Americans already have this cruel, vicious and incurable disease, and ahorrific 50 million around the world. That’s 50 million death sentences. Ten million more get it every year.\nThe drug industry developed five vaccines in one year for COVID-19, a disease associated with the deaths of 3.7 million people world-wide. Alzheimer’s treatments? Oh, one for every 20 years.\nLet’s be honest: Many people subconsciously shrug off this issue on the principle that Alzheimer’s will only happen to someone else. Alas, many of the people reading this article are going to get this disease. For many more, your father, mother, wife or husband will get it. Or a sibling or close friend. At which point, the “hey, maybe we should have made this a bigger national priority” argument will strike, but too late to help.\nThis is the context worth bearing in mind when we hear about drugs getting approved—and, just as importantly, when we hear people demagoguing about “greedy” drug companies and “overpriced” drugs. It’s not just this new Alzheimer’s drug, either.\nIf “drug” companies are making out like bandits, someone really has to explain to me why it doesn’t show up in the…er…stock prices. In the past decade, investors the iShares U.S. Pharmaceuticals exchange-traded fundIHE,+0.61%have made far lower returns than they could have done just by randomly picking a bunch of non-pharmaceutical stocks out of the newspaper. These companies have been worse investments than a simple S&P 500SPX,-0.08%index fund like the SPDR S&P 500 ETFSPY,-0.10%,or the Invesco S&P 500 Equal Weight ETFRSP,-0.18%.\nEven Biogen itself had substantially underperformed the broader stock market index for a decade. Until Monday.\nNo, the industry returns aren’t terrible. But they are hardly the giant free oil well that critics sometimes suggest. I checked out the data from Dartmouth College finance professor Kenneth French, who has tracked stock market returns by industry going back decades. Going all the way back to the 1920s, according to his numbers, the pharmaceuticals industry barely cracks the top one-third of all industries by stock returns. So far this millennium, the total returns from major pharmaceutical companies have been about a third less than those from the S&P 500 index. Biotechs have done much better, but they were a much smaller sector. And even biotech has trailed the returns of alcohol and tobacco companies.\nHow are we going to get billions of dollars more capital invested in curing Alzheimer’s and diabetes and cancer when investors can make more money investing in making booze and cigarettes? This is upside down.\nMeanwhile the regulation are all messed up and back to front as well.This headline says it all: “FDA Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works.”\nThis is nuts. Maybe the new treatment makes things better, maybe it doesn’t. Apparently people aren’t certain. It’s hardly a surprise: The treatment is new, and the disease is complicated. But the first question to ask isn’t whether it makes things better, but whether it makes things worse. The current situation is catastrophic for anyone with the disease. People are dying. Lives are being destroyed.\nWaiting to be sure treatment works would be like falling out of a plane with a parachute on, but hesitating to pull the cord because, well, it might not work. It suggests a basic misunderstanding of game theory. (Or common sense.)\nIt’s one thing to hesitate about approving a new drug for a nonfatal illness. You don’t want to make people sicker, or cause needless suffering or death. But with this kind of illness that really doesn’t apply.\nAnyone who says “oh, no, we need to be really careful, and if need be delay these new treatments for years to make sure they are absolutely 100% safe” is speaking from a position of privilege. They should try saying that to someone watching a loved one be destroyed by the illness. It’s easy to play that card when it’s not happening to you, or someone you love.\nA look through the Biogen’s public filings tells the sorry story. This new Alzheimer’s treatment entered Phase 3 trials in 2015—six years ago. Did I mention it took one year to get COVID vaccines to market?\nMeanwhile, check out all the costs associated with developing this treatment. Biogen struck a collaboration deal with Eisai to work on this drug in 2014. Since then the two of them have spent a total of $1.1 billion on it. If it hadn’t been approved, that’s $1.1 billion down the drain.\nI want more of these treatments. And I want them quickly, not every two decades. I want trillions pouring into this industry. And I know that lower returns, and more bureaucracy, aren’t the way to get them.\nNone of this, of course, means blind, passive or foolish naiveté about the drug industry or pricing. Drug manufacturers spend about $160 million a year on lobbying, and people involved in the business donated nearly $30 million a year to politicians running for office. Look through the proxy statements and you’ll see plenty of Big Pharma CEOs living offthe fatta the lan(like lots of other CEOs).Yes, of course Medicare should have greater freedom to negotiate drug prices.\nFew people know more about malfeasance and greed in the drug industry than investigative journalist Gerald Posner, who literally wrote the book on it —Pharma: Greed, Lies, and the Poisoning Of America.\n“Most of the time I agree with your take,” he tells me. “FDA red tape bureaucracy is slow and costly and good R&D can cost a fortune, all with no guarantee of success. So risk takers, i.e. drug companies, should be rewarded with financial incentives.”\nBut, he adds, U.S. drug companies are already getting plenty of help. The U.S. has the longest patent protections of any major economy. He adds that big U.S. pharma companies get huge research support from taxpayers through the National Institute for Health.\n“From 2010 through 2016, every one of the 210 drugs approved for sale by the FDA were completely or in part funded by the NIH,” he says. The fund came to more than $100 billion, he adds.\nAll good points. But I fear that as long as it’s more profitable to invest in cigarettes or booze than it is in curing Alzheimer’s, we will all be left with Plan B for our old age: Hoping and praying we don’t get Alzheimer’s.","news_type":1},"isVote":1,"tweetType":1,"viewCount":123,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114285077,"gmtCreate":1623075562299,"gmtModify":1634037219001,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Hmmmm","listText":"Hmmmm","text":"Hmmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/114285077","repostId":"1126396501","repostType":4,"isVote":1,"tweetType":1,"viewCount":102,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114067750,"gmtCreate":1623036984970,"gmtModify":1634095984428,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Not bad","listText":"Not bad","text":"Not bad","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/114067750","repostId":"1144781953","repostType":4,"repost":{"id":"1144781953","pubTimestamp":1623029453,"share":"https://www.laohu8.com/m/news/1144781953?lang=&edition=full","pubTime":"2021-06-07 09:30","market":"fut","language":"en","title":"WTI Oil Tops $70 for First Time Since 2018 as Market Tightens","url":"https://stock-news.laohu8.com/highlight/detail?id=1144781953","media":"Bloomberg","summary":"(Bloomberg) -- Oil in New York topped $70 a barrel for the first time since October 2018 as upbeat c","content":"<p>(Bloomberg) -- Oil in New York topped $70 a barrel for the first time since October 2018 as upbeat comments on the market from major trader Vitol Group added to optimism over the global demand recovery.</p><p>Futures rose as much as 0.6% after posting a second weekly gain, while global Brent traded above $72 a barrel. OPEC+ appears in control of crude prices, with U.S. production lagging pre-pandemic levels, Mike Muller, Vitol’s head of Asia, said at a conference on Sunday. The alliance is returning supply after output cuts helped to tighten the market.</p><p>A robust rebound from the virus in the U.S., China and Europe has driven prices more than 40% higher this year, although the Covid-19 comeback in Asia is a reminder that the recovery will be uneven. Russia’s Rosneft PJSC, meanwhile, warned of an impending shortfall in supply as global producers increasingly channel funds into a “hasty” energy transition.</p><p>“I expect crude oil to continue to push higher,” said Daniel Hynes, senior commodities strategist at Australia and New Zealand Banking Group Ltd. “The focus remains on demand, with traffic data suggesting the summer driving season should be positive.”</p><p>The market has firmed in a bullish structure. The prompt timespread for Brent is 41 cents in backwardation -- where near-dated prices are more expensive than later-dated ones. That compares with 37 cents a week earlier.</p><p>The decline in U.S. drilling and output makes OPEC+’s job of managing markets easier, Vitol’s Muller said at an event hosted by consultant Gulf Intelligence. Given delays in talks between Tehran and world powers on reviving a nuclear deal, it’s less likely more Iranian crude supply will hit the market before the fourth quarter, he added.</p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WTI Oil Tops $70 for First Time Since 2018 as Market Tightens</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWTI Oil Tops $70 for First Time Since 2018 as Market Tightens\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-07 09:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/oil-steady-near-2018-high-230212928.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Oil in New York topped $70 a barrel for the first time since October 2018 as upbeat comments on the market from major trader Vitol Group added to optimism over the global demand ...</p>\n\n<a href=\"https://finance.yahoo.com/news/oil-steady-near-2018-high-230212928.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://finance.yahoo.com/news/oil-steady-near-2018-high-230212928.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144781953","content_text":"(Bloomberg) -- Oil in New York topped $70 a barrel for the first time since October 2018 as upbeat comments on the market from major trader Vitol Group added to optimism over the global demand recovery.Futures rose as much as 0.6% after posting a second weekly gain, while global Brent traded above $72 a barrel. OPEC+ appears in control of crude prices, with U.S. production lagging pre-pandemic levels, Mike Muller, Vitol’s head of Asia, said at a conference on Sunday. The alliance is returning supply after output cuts helped to tighten the market.A robust rebound from the virus in the U.S., China and Europe has driven prices more than 40% higher this year, although the Covid-19 comeback in Asia is a reminder that the recovery will be uneven. Russia’s Rosneft PJSC, meanwhile, warned of an impending shortfall in supply as global producers increasingly channel funds into a “hasty” energy transition.“I expect crude oil to continue to push higher,” said Daniel Hynes, senior commodities strategist at Australia and New Zealand Banking Group Ltd. “The focus remains on demand, with traffic data suggesting the summer driving season should be positive.”The market has firmed in a bullish structure. The prompt timespread for Brent is 41 cents in backwardation -- where near-dated prices are more expensive than later-dated ones. That compares with 37 cents a week earlier.The decline in U.S. drilling and output makes OPEC+’s job of managing markets easier, Vitol’s Muller said at an event hosted by consultant Gulf Intelligence. Given delays in talks between Tehran and world powers on reviving a nuclear deal, it’s less likely more Iranian crude supply will hit the market before the fourth quarter, he added.","news_type":1},"isVote":1,"tweetType":1,"viewCount":68,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114067997,"gmtCreate":1623036925419,"gmtModify":1634095984996,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Hmm","listText":"Hmm","text":"Hmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/114067997","repostId":"1143555139","repostType":4,"repost":{"id":"1143555139","pubTimestamp":1623036436,"share":"https://www.laohu8.com/m/news/1143555139?lang=&edition=full","pubTime":"2021-06-07 11:27","market":"fut","language":"en","title":"Colorado Governor Wants to Allow Residents to Pay State Taxes in Crypto","url":"https://stock-news.laohu8.com/highlight/detail?id=1143555139","media":"fool","summary":"Is it possible to pay state taxes by using crypto? This state wants to make that a reality.Colorado ","content":"<p><i>Is it possible to pay state taxes by using crypto? This state wants to make that a reality.</i></p><p>Colorado Governor Jared Polis hopes to one day allow Colorado residents to pay their state taxes usingcryptocurrency.</p><p>Polis, a longtime supporter of digital currencies, was the first political candidate to accept Bitcoin campaign donations in 2014. He recently spoke at the virtual Consensus 2021 event organized by CoinDesk. There, he stated he'd \"be thrilled to be the first state to let you pay your taxes in a variety of cryptos.\"</p><p>He also spoke about his state's involvement in technology, noting, \"Colorado is and will be the center for blockchain innovation in the United States, attracting investments and good jobs and innovators in infrastructure, digital identity, [and] individual data security in the private and public sector.\"</p><p>Polis didn't explain in detail how he hoped to make this a reality. For now, he mentioned that he would need to speak with the Director of Revenue, Mark Ferrandino, to learn more about the possibility.</p><p>Have other states allowed crypto tax payments in the past?</p><p>While no states currently allow for state taxes to be paid in crypto, the idea isn't new. Ohio first allowed Bitcoin to be used to pay tax bills in 2018. This was made possible by using BitPay, a third-party payment service provider.</p><p>However, this service was only available to business owners -- not individual taxpayers. And it was a short-lived program. In 2019, Ohio treasurer Robert Sprague suspended this service to look into the legalities. Whether the program will start up again in the future or if the program will allow individuals to pay their taxes with cryptocurrency remains uncertain.</p><p>Other states have also considered similar programs but never made those programs a reality. The lack of state legislation to support these measures likely stands in the way.</p><p>Will paying with crypto become the norm?</p><p>While you can't pay your state taxes with crypto right now, there are other ways to use your crypto to make purchases. Some big brands like Overstock, Microsoft, and AT&amp;T accept crypto payments.</p><p>Recently, Paypal announced that U.S users couldpay with crypto. Using its Crypto Checkout service, anyone with cryptocurrency holdings in the U.S. can pay for purchases with Bitcoin, Ethereum, Bitcoin Cash, or Litecoin. As one of the most popular online payment solutions, that's a big deal.</p><p>It'll be interesting to see how more businesses adapt to the rise of digital currencies and whether more companies will allow customers to pay for products and services with cryptocurrency. Will states begin to adopt legislation to allow for cryptocurrency to be used to pay taxes? We will have to wait and see when or if that might happen.</p><p>If you're wondering \"what is cryptocurrency?\" make sure to learn more about the basics before you invest.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Colorado Governor Wants to Allow Residents to Pay State Taxes in Crypto</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nColorado Governor Wants to Allow Residents to Pay State Taxes in Crypto\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-07 11:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/the-ascent/cryptocurrency/articles/colorado-governor-wants-to-allow-residents-to-pay-state-taxes-in-crypto/><strong>fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Is it possible to pay state taxes by using crypto? This state wants to make that a reality.Colorado Governor Jared Polis hopes to one day allow Colorado residents to pay their state taxes ...</p>\n\n<a href=\"https://www.fool.com/the-ascent/cryptocurrency/articles/colorado-governor-wants-to-allow-residents-to-pay-state-taxes-in-crypto/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/the-ascent/cryptocurrency/articles/colorado-governor-wants-to-allow-residents-to-pay-state-taxes-in-crypto/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1143555139","content_text":"Is it possible to pay state taxes by using crypto? This state wants to make that a reality.Colorado Governor Jared Polis hopes to one day allow Colorado residents to pay their state taxes usingcryptocurrency.Polis, a longtime supporter of digital currencies, was the first political candidate to accept Bitcoin campaign donations in 2014. He recently spoke at the virtual Consensus 2021 event organized by CoinDesk. There, he stated he'd \"be thrilled to be the first state to let you pay your taxes in a variety of cryptos.\"He also spoke about his state's involvement in technology, noting, \"Colorado is and will be the center for blockchain innovation in the United States, attracting investments and good jobs and innovators in infrastructure, digital identity, [and] individual data security in the private and public sector.\"Polis didn't explain in detail how he hoped to make this a reality. For now, he mentioned that he would need to speak with the Director of Revenue, Mark Ferrandino, to learn more about the possibility.Have other states allowed crypto tax payments in the past?While no states currently allow for state taxes to be paid in crypto, the idea isn't new. Ohio first allowed Bitcoin to be used to pay tax bills in 2018. This was made possible by using BitPay, a third-party payment service provider.However, this service was only available to business owners -- not individual taxpayers. And it was a short-lived program. In 2019, Ohio treasurer Robert Sprague suspended this service to look into the legalities. Whether the program will start up again in the future or if the program will allow individuals to pay their taxes with cryptocurrency remains uncertain.Other states have also considered similar programs but never made those programs a reality. The lack of state legislation to support these measures likely stands in the way.Will paying with crypto become the norm?While you can't pay your state taxes with crypto right now, there are other ways to use your crypto to make purchases. Some big brands like Overstock, Microsoft, and AT&T accept crypto payments.Recently, Paypal announced that U.S users couldpay with crypto. Using its Crypto Checkout service, anyone with cryptocurrency holdings in the U.S. can pay for purchases with Bitcoin, Ethereum, Bitcoin Cash, or Litecoin. As one of the most popular online payment solutions, that's a big deal.It'll be interesting to see how more businesses adapt to the rise of digital currencies and whether more companies will allow customers to pay for products and services with cryptocurrency. Will states begin to adopt legislation to allow for cryptocurrency to be used to pay taxes? We will have to wait and see when or if that might happen.If you're wondering \"what is cryptocurrency?\" make sure to learn more about the basics before you invest.","news_type":1},"isVote":1,"tweetType":1,"viewCount":96,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":117542129,"gmtCreate":1623154023161,"gmtModify":1634036405390,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Please like and comment for me","listText":"Please like and comment for me","text":"Please like and comment for me","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/117542129","repostId":"1154765176","repostType":4,"repost":{"id":"1154765176","pubTimestamp":1623145510,"share":"https://www.laohu8.com/m/news/1154765176?lang=&edition=full","pubTime":"2021-06-08 17:45","market":"us","language":"en","title":"Amazon Stock: Has It Produced The Most Alpha In Big Tech?","url":"https://stock-news.laohu8.com/highlight/detail?id=1154765176","media":"The Street","summary":"A long-term investment in Amazon stock has historically produced outsized returns. But has AMZN been the best Big Tech player at producing alpha?The Amazon Maven faces off six mega-cap stocks.A few days ago, the Amazon Maven explained howa mere $100 monthly investment in Amazon stock  -Get Report since the company’s 1997 IPO would have led to riches: $2.7 million today. It is hard to imagine a methodical, long-term investment having performed as well as this one.But has AMZN shares created the m","content":"<blockquote><b>A long-term investment in Amazon stock has historically produced outsized returns. But has AMZN been the best Big Tech player at producing alpha? The Amazon Maven faces off six mega-cap stocks.</b></blockquote><p>A&nbsp;few days ago, the Amazon Maven explained howa mere $100 monthly investment in Amazon stock&nbsp;(<b>AMZN</b>) -Get Report&nbsp;since the company’s 1997 IPO would have led to riches: $2.7 million today. It is hard to imagine a methodical, long-term investment having performed as well as this one.</p><p>But has AMZN shares created the most alpha within the mega-cap tech universe? Could investors have done much better by betting on names like Apple&nbsp;(<b>AAPL</b>) or Microsoft&nbsp;(<b>MSFT</b>) instead?</p><p><b>What is alpha?</b></p><p>First, it helps to look closer at the concept of alpha. Generally, alpha is thought to be the returns that an investor can earn in excess of a benchmark. In other words: how much has a stock or portfolio risen relative to the S&amp;P 500 or the Nasdaq? Investopediasummarizesas follows:</p><blockquote>Alpha (α) is a term used in investing to describe an investment strategy's ability to beat the market, or its ‘edge’. Alpha is also referred to as ‘excess return’ or ‘abnormal rate of return’.</blockquote><p>To me, this is a good start. But alpha should also consider one crucial factor: risk.</p><p>Beating the S&amp;P 500 might simply mean higher sensitivity to market forces (i.e. beta). So, the better question is: how much return can a stock produce<b><i>relative to risk</i></b>. I believe that this is a more complete view of alpha.</p><p><b>Amazon stock vs. the rest</b></p><p>Considering absolute returns only, Amazon stock ranks remarkably high within Big Tech for historical share price performance. The chart below shows that, over the past 10 years, AMZN has only lagged Tesla (TSLA) in annualized gains.</p><p><img src=\"https://static.tigerbbs.com/8474b2c893b04f99bbc62cbf3aaa9bec\" tg-width=\"683\" tg-height=\"409\" referrerpolicy=\"no-referrer\">Now, let me introduce risk to the equation. Risk is often defined (maybe too simplistically) as volatility. The more a stock rises and falls from minute to minute, or day to day, or week to week, the riskier it is.</p><p>So, one way to assess a stock’s returns relative to risk, thus giving us a better idea of its alpha potential, is to divide annualized returns by annualized volatility. By this methodology, Amazon stock loses its silver medal to Microsoft.</p><p><img src=\"https://static.tigerbbs.com/760869278d2e71f120fe4f1fc108de5a\" tg-width=\"680\" tg-height=\"405\" referrerpolicy=\"no-referrer\">One takeaway here is that, over the past decade, Amazon has achieved higher returns than any other FAAMG stock, but not without exposing investors to more volatility. If history repeats, investors should expect high returns to come alongside relatively sharper ups and downs as well.</p><p>Another way to think about risk, one that I have favored recently, is to think about sizable losses. A good question to ask would be: how much has a stock produced in average annual returns relative to its worst trailing 12-month (TTM) performance?</p><p>Using this methodology, not only does Amazon stock lose its silver medal, but it also drops out of the podium altogether. See chart below, and notice that Facebook has also performed better than Amazon in the past ten years in loss-adjusted terms.</p><p><img src=\"https://static.tigerbbs.com/affd59dcb14135f4a2cc892ad143ec26\" tg-width=\"683\" tg-height=\"405\" referrerpolicy=\"no-referrer\">Figure 4: Ratio: Annualized return vs. Worst TTM return.</p><p>DM Martins Research</p><p>Amazon, in fact, has one of the worst track records within Big Tech when it comes to sharp losses. By November 2008, AMZN had seen 57% of its value evaporate over the previous year. Only Alphabet, around the same time, performed any worse than this.</p><p><b>The key takeaways for investors</b></p><p>Having said the above, I think that Amazon investors can learn a few lessons from this historical price action analysis:</p><ul><li>Amazon has been a high-performing name, both since the IPO and over the past decade. In absolute terms, it is hard to find many stocks that have consistently delivered outsized returns.</li><li>Once risk is introduced to the discussion, Amazon stock’s performance goes from “outstanding” to a less exhilarating “solid”. Peers like Tesla, Microsoft and even Facebook seem to have been better alpha producers. In the 10 years that preceded the pandemic, in fact, Amazon’s volatility-adjusted returns were about the same as the S&amp;P 500’s.</li><li>AMZN investors should understand that the stock could continue to produce outsized gains, but also endure higher volatility and sharper losses, as it has in the last decade or more.</li><li>As always, past performance is not a guarantee of future results. Use history as a rough guide to set expectations, but understand that share price behavior can be quite different going forward.</li></ul><p><b>Twitter speaks</b></p><p>Pop quiz: relative to volatility (that is, in risk-adjusted terms), which of the following mega-cap tech stock has delivered the best returns in the past 10 year? Leave your vote below and follow The Amazon Maven on Twitter!</p><p><img src=\"https://static.tigerbbs.com/e679074ff1db7d9f81416239eecca1dd\" tg-width=\"584\" tg-height=\"448\" referrerpolicy=\"no-referrer\"></p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amazon Stock: Has It Produced The Most Alpha In Big Tech?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmazon Stock: Has It Produced The Most Alpha In Big Tech?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 17:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/amazon/stock/amazon-stock-has-it-produced-the-most-alpha-in-big-tech><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>A long-term investment in Amazon stock has historically produced outsized returns. But has AMZN been the best Big Tech player at producing alpha? The Amazon Maven faces off six mega-cap stocks.A few ...</p>\n\n<a href=\"https://www.thestreet.com/amazon/stock/amazon-stock-has-it-produced-the-most-alpha-in-big-tech\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊"},"source_url":"https://www.thestreet.com/amazon/stock/amazon-stock-has-it-produced-the-most-alpha-in-big-tech","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154765176","content_text":"A long-term investment in Amazon stock has historically produced outsized returns. But has AMZN been the best Big Tech player at producing alpha? The Amazon Maven faces off six mega-cap stocks.A few days ago, the Amazon Maven explained howa mere $100 monthly investment in Amazon stock (AMZN) -Get Report since the company’s 1997 IPO would have led to riches: $2.7 million today. It is hard to imagine a methodical, long-term investment having performed as well as this one.But has AMZN shares created the most alpha within the mega-cap tech universe? Could investors have done much better by betting on names like Apple (AAPL) or Microsoft (MSFT) instead?What is alpha?First, it helps to look closer at the concept of alpha. Generally, alpha is thought to be the returns that an investor can earn in excess of a benchmark. In other words: how much has a stock or portfolio risen relative to the S&P 500 or the Nasdaq? Investopediasummarizesas follows:Alpha (α) is a term used in investing to describe an investment strategy's ability to beat the market, or its ‘edge’. Alpha is also referred to as ‘excess return’ or ‘abnormal rate of return’.To me, this is a good start. But alpha should also consider one crucial factor: risk.Beating the S&P 500 might simply mean higher sensitivity to market forces (i.e. beta). So, the better question is: how much return can a stock producerelative to risk. I believe that this is a more complete view of alpha.Amazon stock vs. the restConsidering absolute returns only, Amazon stock ranks remarkably high within Big Tech for historical share price performance. The chart below shows that, over the past 10 years, AMZN has only lagged Tesla (TSLA) in annualized gains.Now, let me introduce risk to the equation. Risk is often defined (maybe too simplistically) as volatility. The more a stock rises and falls from minute to minute, or day to day, or week to week, the riskier it is.So, one way to assess a stock’s returns relative to risk, thus giving us a better idea of its alpha potential, is to divide annualized returns by annualized volatility. By this methodology, Amazon stock loses its silver medal to Microsoft.One takeaway here is that, over the past decade, Amazon has achieved higher returns than any other FAAMG stock, but not without exposing investors to more volatility. If history repeats, investors should expect high returns to come alongside relatively sharper ups and downs as well.Another way to think about risk, one that I have favored recently, is to think about sizable losses. A good question to ask would be: how much has a stock produced in average annual returns relative to its worst trailing 12-month (TTM) performance?Using this methodology, not only does Amazon stock lose its silver medal, but it also drops out of the podium altogether. See chart below, and notice that Facebook has also performed better than Amazon in the past ten years in loss-adjusted terms.Figure 4: Ratio: Annualized return vs. Worst TTM return.DM Martins ResearchAmazon, in fact, has one of the worst track records within Big Tech when it comes to sharp losses. By November 2008, AMZN had seen 57% of its value evaporate over the previous year. Only Alphabet, around the same time, performed any worse than this.The key takeaways for investorsHaving said the above, I think that Amazon investors can learn a few lessons from this historical price action analysis:Amazon has been a high-performing name, both since the IPO and over the past decade. In absolute terms, it is hard to find many stocks that have consistently delivered outsized returns.Once risk is introduced to the discussion, Amazon stock’s performance goes from “outstanding” to a less exhilarating “solid”. Peers like Tesla, Microsoft and even Facebook seem to have been better alpha producers. In the 10 years that preceded the pandemic, in fact, Amazon’s volatility-adjusted returns were about the same as the S&P 500’s.AMZN investors should understand that the stock could continue to produce outsized gains, but also endure higher volatility and sharper losses, as it has in the last decade or more.As always, past performance is not a guarantee of future results. Use history as a rough guide to set expectations, but understand that share price behavior can be quite different going forward.Twitter speaksPop quiz: relative to volatility (that is, in risk-adjusted terms), which of the following mega-cap tech stock has delivered the best returns in the past 10 year? Leave your vote below and follow The Amazon Maven on Twitter!","news_type":1},"isVote":1,"tweetType":1,"viewCount":136,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":185221565,"gmtCreate":1623654921057,"gmtModify":1631893946625,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Pls comment and like with many thanks","listText":"Pls comment and like with many thanks","text":"Pls comment and like with many thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/185221565","repostId":"1146430910","repostType":4,"isVote":1,"tweetType":1,"viewCount":312,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120825133,"gmtCreate":1624319468622,"gmtModify":1631893946608,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/120825133","repostId":"1167650307","repostType":4,"repost":{"id":"1167650307","pubTimestamp":1624317912,"share":"https://www.laohu8.com/m/news/1167650307?lang=&edition=full","pubTime":"2021-06-22 07:25","market":"us","language":"en","title":"Stocks making the biggest moves after hours: Sanderson Farms, Globalstar & more","url":"https://stock-news.laohu8.com/highlight/detail?id=1167650307","media":"cnbc","summary":"Today's After-Hours Movers:\nAdial Pharmaceuticals (NASDAQ: ADIL)30.3% HIGHER; positive mention at Se","content":"<div>\n<p>Today's After-Hours Movers:\nAdial Pharmaceuticals (NASDAQ: ADIL)30.3% HIGHER; positive mention at SeekingAlpha\nIdera Pharma (NASDAQ: IDRA)18.8% HIGHER; COO Daniel Soland acquired 50,000 shares on June...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/21/stocks-making-the-biggest-moves-after-hours-sanderson-farms-pilgrims-pride-globalstar.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Sanderson Farms, Globalstar & more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Sanderson Farms, Globalstar & more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 07:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/21/stocks-making-the-biggest-moves-after-hours-sanderson-farms-pilgrims-pride-globalstar.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Today's After-Hours Movers:\nAdial Pharmaceuticals (NASDAQ: ADIL)30.3% HIGHER; positive mention at SeekingAlpha\nIdera Pharma (NASDAQ: IDRA)18.8% HIGHER; COO Daniel Soland acquired 50,000 shares on June...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/21/stocks-making-the-biggest-moves-after-hours-sanderson-farms-pilgrims-pride-globalstar.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PPC":"Pilgrim’s Pride Corporation","MVIS":"维视图像","GSAT":"全球星","FANG":"Diamondback Energy"},"source_url":"https://www.cnbc.com/2021/06/21/stocks-making-the-biggest-moves-after-hours-sanderson-farms-pilgrims-pride-globalstar.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1167650307","content_text":"Today's After-Hours Movers:\nAdial Pharmaceuticals (NASDAQ: ADIL)30.3% HIGHER; positive mention at SeekingAlpha\nIdera Pharma (NASDAQ: IDRA)18.8% HIGHER; COO Daniel Soland acquired 50,000 shares on June 18 at $1.19.\nBeyond Air, Inc. (NASDAQ: XAIR)11.8% HIGHER; CEO and Chairman, Steven Lisi, bought 25,000 shares on 06/17 at $5.36. In addition, Director, Robert Carey, bought 350,000 shares on 06/17 at $5.36.\nMicroVision, Inc. (NASDAQ: MVIS) 11.5% LOWER; announced it entered into a $140 million At-the-Market (ATM) equity offering agreement with Craig-Hallum Capital Group.\nAFC Gamma, Inc. (Nasdaq: AFCG) 9.6% LOWER; announced that it has launched an underwritten public offering of 2,750,000 shares of its common stock. AFC Gamma intends to grant the underwriters of the Offering a 30-day option to purchase up to an additional 412,500 shares of common stock.\nSanderson Farms (NASDAQ: SAFM)9% HIGHER; is exploring a sale, according to Dow Jones, citing people familiar with the matter.\nFocus Financial Partners Inc. (NASDAQ: FOCS) 4.9% LOWER; launched an underwritten secondary offering of 7,419,939 shares of its Class A common stock. This amount consists of 7,144,244 shares being offered by certain selling stockholders of Focus affiliated with Kohlberg Kravis Roberts & Co. L.P. (\"KKR\") and 275,695 shares being offered by Focus (the \"Offering\") on behalf of certain of the existing unitholders of Focus Financial Partners, LLC (\"Focus LLC\"), its operating subsidiary. If this offering is consummated on these terms, KKR will no longer own interests in Focus or Focus LLC.\nStar Bulk Carriers Corp. (Nasdaq: SBLK)4.5% LOWER; commencement of a secondary public offering of 2,382,775 of the Companys common shares by funds affiliated with Oaktree Capital Management, L.P. (the Selling Shareholders). Unless otherwise indicated or unless the context requires otherwise, all references in this press release to \"we,\" \"us,\" \"our,\" or similar references, mean Star Bulk Carriers Corp. and, where applicable, its consolidated subsidiaries.\nTupperware Brands Corporation (NYSE: TUP)4.5% HIGHER; announced the prepayment of $58 million of its Term Loan Debt from Angelo Gordon and JP Morgan, and, that its Board of Directors has authorized share repurchases of up to $250 million of the Company's outstanding shares of common stock.\nShoe Carnival, Inc. (Nasdaq: SCVL)3.2% HIGHER; announced today that its Board of Directors has authorized a two-for-one stock split of the Company's common stock\nNutrien Ltd (NYSE: NTR) 2.5% HIGHER; announced today that it has increased its first-half 2021 earnings guidance given the strength in global fertilizer markets and strong operational results. First-half 2021 adjusted net earnings per share (EPS) is expected to be $2.30 to $2.50, up significantly from our previous guidance of $2.00 to $2.20 (first quarter adjusted net earnings per share was $0.29).\nNikola (NASDAQ: NKLA)2.5% LOWER; has filed form S-1 registering a proposed offering of 18,012,845 shares.","news_type":1},"isVote":1,"tweetType":1,"viewCount":317,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":188293635,"gmtCreate":1623441824927,"gmtModify":1634033168950,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/188293635","repostId":"2142572209","repostType":4,"isVote":1,"tweetType":1,"viewCount":107,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":115280689,"gmtCreate":1623000672641,"gmtModify":1634096329589,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Yea","listText":"Yea","text":"Yea","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/115280689","repostId":"1156802172","repostType":4,"isVote":1,"tweetType":1,"viewCount":129,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129947356,"gmtCreate":1624354790375,"gmtModify":1631893946605,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Like and comment.&nbsp; Thank you","listText":"Like and comment.&nbsp; Thank you","text":"Like and comment. Thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/129947356","repostId":"1186919064","repostType":4,"isVote":1,"tweetType":1,"viewCount":418,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":161037621,"gmtCreate":1623896069063,"gmtModify":1631893946617,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Like and comment pls. Thanks 😊","listText":"Like and comment pls. Thanks 😊","text":"Like and comment pls. Thanks 😊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/161037621","repostId":"2144130887","repostType":4,"isVote":1,"tweetType":1,"viewCount":308,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":117543634,"gmtCreate":1623153771328,"gmtModify":1634036407976,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/117543634","repostId":"1127979401","repostType":4,"repost":{"id":"1127979401","pubTimestamp":1623153568,"share":"https://www.laohu8.com/m/news/1127979401?lang=&edition=full","pubTime":"2021-06-08 19:59","market":"us","language":"en","title":"Opinion: Only ‘greedy’ drug companies will cure Alzheimer’s","url":"https://stock-news.laohu8.com/highlight/detail?id=1127979401","media":"marketwatch","summary":"Here’s a question for everyone in Congress and the White House, the federal bureaucracy, and all my ","content":"<p><img src=\"https://static.tigerbbs.com/783580e857537ceb68ca7c6330ee4132\" tg-width=\"1260\" tg-height=\"736\">Here’s a question for everyone in Congress and the White House, the federal bureaucracy, and all my fellow members of the (ahem) “mainstream media.”</p>\n<p>Now that BiogenBIIB,+38.34%has got approval forits new Alzheimer’s drug—the first approved by the FDA in almost 20 years — how much should they be allowed to charge for it?</p>\n<p>What’s the ethically correct figure? What will exempt them from charges of “greed” or “gouging?” What is “too much?”</p>\n<p>The manufacturing cost per pill? The cost plus a small margin? What’s the number?</p>\n<p>I bring this up because few things matter as much for the lives of senior citizens in America—and seniors in the rest of the world—than the development of new drugs. I have personally seen up close how Alzheimer’s destroys people, sometimes as young as their 50s and 60s. This has included close members of my family.</p>\n<p>Some six million Americans already have this cruel, vicious and incurable disease, and ahorrific 50 million around the world. That’s 50 million death sentences. Ten million more get it every year.</p>\n<p>The drug industry developed five vaccines in one year for COVID-19, a disease associated with the deaths of 3.7 million people world-wide. Alzheimer’s treatments? Oh, one for every 20 years.</p>\n<p>Let’s be honest: Many people subconsciously shrug off this issue on the principle that Alzheimer’s will only happen to someone else. Alas, many of the people reading this article are going to get this disease. For many more, your father, mother, wife or husband will get it. Or a sibling or close friend. At which point, the “hey, maybe we should have made this a bigger national priority” argument will strike, but too late to help.</p>\n<p>This is the context worth bearing in mind when we hear about drugs getting approved—and, just as importantly, when we hear people demagoguing about “greedy” drug companies and “overpriced” drugs. It’s not just this new Alzheimer’s drug, either.</p>\n<p>If “drug” companies are making out like bandits, someone really has to explain to me why it doesn’t show up in the…er…stock prices. In the past decade, investors the iShares U.S. Pharmaceuticals exchange-traded fundIHE,+0.61%have made far lower returns than they could have done just by randomly picking a bunch of non-pharmaceutical stocks out of the newspaper. These companies have been worse investments than a simple S&amp;P 500SPX,-0.08%index fund like the SPDR S&amp;P 500 ETFSPY,-0.10%,or the Invesco S&amp;P 500 Equal Weight ETFRSP,-0.18%.</p>\n<p>Even Biogen itself had substantially underperformed the broader stock market index for a decade. Until Monday.</p>\n<p>No, the industry returns aren’t terrible. But they are hardly the giant free oil well that critics sometimes suggest. I checked out the data from Dartmouth College finance professor Kenneth French, who has tracked stock market returns by industry going back decades. Going all the way back to the 1920s, according to his numbers, the pharmaceuticals industry barely cracks the top one-third of all industries by stock returns. So far this millennium, the total returns from major pharmaceutical companies have been about a third less than those from the S&amp;P 500 index. Biotechs have done much better, but they were a much smaller sector. And even biotech has trailed the returns of alcohol and tobacco companies.</p>\n<p>How are we going to get billions of dollars more capital invested in curing Alzheimer’s and diabetes and cancer when investors can make more money investing in making booze and cigarettes? This is upside down.</p>\n<p>Meanwhile the regulation are all messed up and back to front as well.This headline says it all: “FDA Approves Alzheimer’s Drug Despite Fierce Debate Over&nbsp;Whether&nbsp;It Works.”</p>\n<p>This is nuts. Maybe the new treatment makes things better, maybe it doesn’t. Apparently people aren’t certain. It’s hardly a surprise: The treatment is new, and the disease is complicated. But the first question to ask isn’t whether it makes things better, but whether it makes things worse. The current situation is catastrophic for anyone with the disease. People are dying. Lives are being destroyed.</p>\n<p>Waiting to be sure treatment works would be like falling out of a plane with a parachute on, but hesitating to pull the cord because, well, it might not work. It suggests a basic misunderstanding of game theory. (Or common sense.)</p>\n<p>It’s one thing to hesitate about approving a new drug for a nonfatal illness. You don’t want to make people sicker, or cause needless suffering or death. But with this kind of illness that really doesn’t apply.</p>\n<p>Anyone who says “oh, no, we need to be really careful, and if need be delay these new treatments for years to make sure they are absolutely 100% safe” is speaking from a position of privilege. They should try saying that to someone watching a loved one be destroyed by the illness. It’s easy to play that card when it’s not happening to you, or someone you love.</p>\n<p>A look through the Biogen’s public filings tells the sorry story. This new&nbsp;Alzheimer’s&nbsp;treatment entered Phase 3 trials in 2015—six years ago. Did I mention it took one year to get COVID vaccines to market?</p>\n<p>Meanwhile, check out all the costs associated with developing this treatment. Biogen struck a collaboration deal with Eisai to work on this drug in 2014. Since then the two of them have spent a total of $1.1 billion on it. If it hadn’t been approved, that’s $1.1 billion down the drain.</p>\n<p>I want more of these treatments. And I want them quickly, not every two decades. I want trillions pouring into this industry. And I know that lower returns, and more bureaucracy, aren’t the way to get them.</p>\n<p>None of this, of course, means blind, passive or foolish naiveté about the drug industry or pricing. Drug manufacturers spend about $160 million a year on lobbying, and people involved in the business donated nearly $30 million a year to politicians running for office. Look through the proxy statements and you’ll see plenty of Big Pharma CEOs living off<i>the fatta the lan</i>(like lots of other CEOs).Yes, of course Medicare should have greater freedom to negotiate drug prices.</p>\n<p>Few people know more about malfeasance and greed in the drug industry than investigative journalist Gerald Posner, who literally wrote the book on it —Pharma: Greed, Lies, and the Poisoning Of America.</p>\n<p>“Most of the time I agree with your take,” he tells me. “FDA red tape bureaucracy is slow and costly and good R&amp;D can cost a fortune, all with no guarantee of success. So risk takers, i.e. drug companies, should be rewarded with financial incentives.”</p>\n<p>But, he adds, U.S. drug companies are already getting plenty of help. The U.S. has the longest patent protections of any major economy. He adds that big U.S. pharma companies get huge research support from taxpayers through the National Institute for Health.</p>\n<p>“From 2010 through 2016, every one of the 210 drugs approved for sale by the FDA were completely or in part funded by the NIH,” he says. The fund came to more than $100 billion, he adds.</p>\n<p>All good points. But I fear that as long as it’s more profitable to invest in cigarettes or booze than it is in curing Alzheimer’s, we will all be left with Plan B for our old age: Hoping and praying we don’t get Alzheimer’s.</p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Opinion: Only ‘greedy’ drug companies will cure Alzheimer’s</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOpinion: Only ‘greedy’ drug companies will cure Alzheimer’s\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 19:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/only-greedy-drug-companies-will-cure-alzheimers-11623152892?mod=newsviewer_click><strong>marketwatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Here’s a question for everyone in Congress and the White House, the federal bureaucracy, and all my fellow members of the (ahem) “mainstream media.”\nNow that BiogenBIIB,+38.34%has got approval forits ...</p>\n\n<a href=\"https://www.marketwatch.com/story/only-greedy-drug-companies-will-cure-alzheimers-11623152892?mod=newsviewer_click\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.marketwatch.com/story/only-greedy-drug-companies-will-cure-alzheimers-11623152892?mod=newsviewer_click","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1127979401","content_text":"Here’s a question for everyone in Congress and the White House, the federal bureaucracy, and all my fellow members of the (ahem) “mainstream media.”\nNow that BiogenBIIB,+38.34%has got approval forits new Alzheimer’s drug—the first approved by the FDA in almost 20 years — how much should they be allowed to charge for it?\nWhat’s the ethically correct figure? What will exempt them from charges of “greed” or “gouging?” What is “too much?”\nThe manufacturing cost per pill? The cost plus a small margin? What’s the number?\nI bring this up because few things matter as much for the lives of senior citizens in America—and seniors in the rest of the world—than the development of new drugs. I have personally seen up close how Alzheimer’s destroys people, sometimes as young as their 50s and 60s. This has included close members of my family.\nSome six million Americans already have this cruel, vicious and incurable disease, and ahorrific 50 million around the world. That’s 50 million death sentences. Ten million more get it every year.\nThe drug industry developed five vaccines in one year for COVID-19, a disease associated with the deaths of 3.7 million people world-wide. Alzheimer’s treatments? Oh, one for every 20 years.\nLet’s be honest: Many people subconsciously shrug off this issue on the principle that Alzheimer’s will only happen to someone else. Alas, many of the people reading this article are going to get this disease. For many more, your father, mother, wife or husband will get it. Or a sibling or close friend. At which point, the “hey, maybe we should have made this a bigger national priority” argument will strike, but too late to help.\nThis is the context worth bearing in mind when we hear about drugs getting approved—and, just as importantly, when we hear people demagoguing about “greedy” drug companies and “overpriced” drugs. It’s not just this new Alzheimer’s drug, either.\nIf “drug” companies are making out like bandits, someone really has to explain to me why it doesn’t show up in the…er…stock prices. In the past decade, investors the iShares U.S. Pharmaceuticals exchange-traded fundIHE,+0.61%have made far lower returns than they could have done just by randomly picking a bunch of non-pharmaceutical stocks out of the newspaper. These companies have been worse investments than a simple S&P 500SPX,-0.08%index fund like the SPDR S&P 500 ETFSPY,-0.10%,or the Invesco S&P 500 Equal Weight ETFRSP,-0.18%.\nEven Biogen itself had substantially underperformed the broader stock market index for a decade. Until Monday.\nNo, the industry returns aren’t terrible. But they are hardly the giant free oil well that critics sometimes suggest. I checked out the data from Dartmouth College finance professor Kenneth French, who has tracked stock market returns by industry going back decades. Going all the way back to the 1920s, according to his numbers, the pharmaceuticals industry barely cracks the top one-third of all industries by stock returns. So far this millennium, the total returns from major pharmaceutical companies have been about a third less than those from the S&P 500 index. Biotechs have done much better, but they were a much smaller sector. And even biotech has trailed the returns of alcohol and tobacco companies.\nHow are we going to get billions of dollars more capital invested in curing Alzheimer’s and diabetes and cancer when investors can make more money investing in making booze and cigarettes? This is upside down.\nMeanwhile the regulation are all messed up and back to front as well.This headline says it all: “FDA Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works.”\nThis is nuts. Maybe the new treatment makes things better, maybe it doesn’t. Apparently people aren’t certain. It’s hardly a surprise: The treatment is new, and the disease is complicated. But the first question to ask isn’t whether it makes things better, but whether it makes things worse. The current situation is catastrophic for anyone with the disease. People are dying. Lives are being destroyed.\nWaiting to be sure treatment works would be like falling out of a plane with a parachute on, but hesitating to pull the cord because, well, it might not work. It suggests a basic misunderstanding of game theory. (Or common sense.)\nIt’s one thing to hesitate about approving a new drug for a nonfatal illness. You don’t want to make people sicker, or cause needless suffering or death. But with this kind of illness that really doesn’t apply.\nAnyone who says “oh, no, we need to be really careful, and if need be delay these new treatments for years to make sure they are absolutely 100% safe” is speaking from a position of privilege. They should try saying that to someone watching a loved one be destroyed by the illness. It’s easy to play that card when it’s not happening to you, or someone you love.\nA look through the Biogen’s public filings tells the sorry story. This new Alzheimer’s treatment entered Phase 3 trials in 2015—six years ago. Did I mention it took one year to get COVID vaccines to market?\nMeanwhile, check out all the costs associated with developing this treatment. Biogen struck a collaboration deal with Eisai to work on this drug in 2014. Since then the two of them have spent a total of $1.1 billion on it. If it hadn’t been approved, that’s $1.1 billion down the drain.\nI want more of these treatments. And I want them quickly, not every two decades. I want trillions pouring into this industry. And I know that lower returns, and more bureaucracy, aren’t the way to get them.\nNone of this, of course, means blind, passive or foolish naiveté about the drug industry or pricing. Drug manufacturers spend about $160 million a year on lobbying, and people involved in the business donated nearly $30 million a year to politicians running for office. Look through the proxy statements and you’ll see plenty of Big Pharma CEOs living offthe fatta the lan(like lots of other CEOs).Yes, of course Medicare should have greater freedom to negotiate drug prices.\nFew people know more about malfeasance and greed in the drug industry than investigative journalist Gerald Posner, who literally wrote the book on it —Pharma: Greed, Lies, and the Poisoning Of America.\n“Most of the time I agree with your take,” he tells me. “FDA red tape bureaucracy is slow and costly and good R&D can cost a fortune, all with no guarantee of success. So risk takers, i.e. drug companies, should be rewarded with financial incentives.”\nBut, he adds, U.S. drug companies are already getting plenty of help. The U.S. has the longest patent protections of any major economy. He adds that big U.S. pharma companies get huge research support from taxpayers through the National Institute for Health.\n“From 2010 through 2016, every one of the 210 drugs approved for sale by the FDA were completely or in part funded by the NIH,” he says. The fund came to more than $100 billion, he adds.\nAll good points. But I fear that as long as it’s more profitable to invest in cigarettes or booze than it is in curing Alzheimer’s, we will all be left with Plan B for our old age: Hoping and praying we don’t get Alzheimer’s.","news_type":1},"isVote":1,"tweetType":1,"viewCount":123,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114067997,"gmtCreate":1623036925419,"gmtModify":1634095984996,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Hmm","listText":"Hmm","text":"Hmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/114067997","repostId":"1143555139","repostType":4,"repost":{"id":"1143555139","pubTimestamp":1623036436,"share":"https://www.laohu8.com/m/news/1143555139?lang=&edition=full","pubTime":"2021-06-07 11:27","market":"fut","language":"en","title":"Colorado Governor Wants to Allow Residents to Pay State Taxes in Crypto","url":"https://stock-news.laohu8.com/highlight/detail?id=1143555139","media":"fool","summary":"Is it possible to pay state taxes by using crypto? This state wants to make that a reality.Colorado ","content":"<p><i>Is it possible to pay state taxes by using crypto? This state wants to make that a reality.</i></p><p>Colorado Governor Jared Polis hopes to one day allow Colorado residents to pay their state taxes usingcryptocurrency.</p><p>Polis, a longtime supporter of digital currencies, was the first political candidate to accept Bitcoin campaign donations in 2014. He recently spoke at the virtual Consensus 2021 event organized by CoinDesk. There, he stated he'd \"be thrilled to be the first state to let you pay your taxes in a variety of cryptos.\"</p><p>He also spoke about his state's involvement in technology, noting, \"Colorado is and will be the center for blockchain innovation in the United States, attracting investments and good jobs and innovators in infrastructure, digital identity, [and] individual data security in the private and public sector.\"</p><p>Polis didn't explain in detail how he hoped to make this a reality. For now, he mentioned that he would need to speak with the Director of Revenue, Mark Ferrandino, to learn more about the possibility.</p><p>Have other states allowed crypto tax payments in the past?</p><p>While no states currently allow for state taxes to be paid in crypto, the idea isn't new. Ohio first allowed Bitcoin to be used to pay tax bills in 2018. This was made possible by using BitPay, a third-party payment service provider.</p><p>However, this service was only available to business owners -- not individual taxpayers. And it was a short-lived program. In 2019, Ohio treasurer Robert Sprague suspended this service to look into the legalities. Whether the program will start up again in the future or if the program will allow individuals to pay their taxes with cryptocurrency remains uncertain.</p><p>Other states have also considered similar programs but never made those programs a reality. The lack of state legislation to support these measures likely stands in the way.</p><p>Will paying with crypto become the norm?</p><p>While you can't pay your state taxes with crypto right now, there are other ways to use your crypto to make purchases. Some big brands like Overstock, Microsoft, and AT&amp;T accept crypto payments.</p><p>Recently, Paypal announced that U.S users couldpay with crypto. Using its Crypto Checkout service, anyone with cryptocurrency holdings in the U.S. can pay for purchases with Bitcoin, Ethereum, Bitcoin Cash, or Litecoin. As one of the most popular online payment solutions, that's a big deal.</p><p>It'll be interesting to see how more businesses adapt to the rise of digital currencies and whether more companies will allow customers to pay for products and services with cryptocurrency. Will states begin to adopt legislation to allow for cryptocurrency to be used to pay taxes? We will have to wait and see when or if that might happen.</p><p>If you're wondering \"what is cryptocurrency?\" make sure to learn more about the basics before you invest.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Colorado Governor Wants to Allow Residents to Pay State Taxes in Crypto</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nColorado Governor Wants to Allow Residents to Pay State Taxes in Crypto\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-07 11:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/the-ascent/cryptocurrency/articles/colorado-governor-wants-to-allow-residents-to-pay-state-taxes-in-crypto/><strong>fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Is it possible to pay state taxes by using crypto? This state wants to make that a reality.Colorado Governor Jared Polis hopes to one day allow Colorado residents to pay their state taxes ...</p>\n\n<a href=\"https://www.fool.com/the-ascent/cryptocurrency/articles/colorado-governor-wants-to-allow-residents-to-pay-state-taxes-in-crypto/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/the-ascent/cryptocurrency/articles/colorado-governor-wants-to-allow-residents-to-pay-state-taxes-in-crypto/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1143555139","content_text":"Is it possible to pay state taxes by using crypto? This state wants to make that a reality.Colorado Governor Jared Polis hopes to one day allow Colorado residents to pay their state taxes usingcryptocurrency.Polis, a longtime supporter of digital currencies, was the first political candidate to accept Bitcoin campaign donations in 2014. He recently spoke at the virtual Consensus 2021 event organized by CoinDesk. There, he stated he'd \"be thrilled to be the first state to let you pay your taxes in a variety of cryptos.\"He also spoke about his state's involvement in technology, noting, \"Colorado is and will be the center for blockchain innovation in the United States, attracting investments and good jobs and innovators in infrastructure, digital identity, [and] individual data security in the private and public sector.\"Polis didn't explain in detail how he hoped to make this a reality. For now, he mentioned that he would need to speak with the Director of Revenue, Mark Ferrandino, to learn more about the possibility.Have other states allowed crypto tax payments in the past?While no states currently allow for state taxes to be paid in crypto, the idea isn't new. Ohio first allowed Bitcoin to be used to pay tax bills in 2018. This was made possible by using BitPay, a third-party payment service provider.However, this service was only available to business owners -- not individual taxpayers. And it was a short-lived program. In 2019, Ohio treasurer Robert Sprague suspended this service to look into the legalities. Whether the program will start up again in the future or if the program will allow individuals to pay their taxes with cryptocurrency remains uncertain.Other states have also considered similar programs but never made those programs a reality. The lack of state legislation to support these measures likely stands in the way.Will paying with crypto become the norm?While you can't pay your state taxes with crypto right now, there are other ways to use your crypto to make purchases. Some big brands like Overstock, Microsoft, and AT&T accept crypto payments.Recently, Paypal announced that U.S users couldpay with crypto. Using its Crypto Checkout service, anyone with cryptocurrency holdings in the U.S. can pay for purchases with Bitcoin, Ethereum, Bitcoin Cash, or Litecoin. As one of the most popular online payment solutions, that's a big deal.It'll be interesting to see how more businesses adapt to the rise of digital currencies and whether more companies will allow customers to pay for products and services with cryptocurrency. Will states begin to adopt legislation to allow for cryptocurrency to be used to pay taxes? We will have to wait and see when or if that might happen.If you're wondering \"what is cryptocurrency?\" make sure to learn more about the basics before you invest.","news_type":1},"isVote":1,"tweetType":1,"viewCount":96,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114065742,"gmtCreate":1623036881786,"gmtModify":1634095985953,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/114065742","repostId":"2141926289","repostType":4,"isVote":1,"tweetType":1,"viewCount":110,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":128641808,"gmtCreate":1624515467904,"gmtModify":1631893946604,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Like.and comments pls","listText":"Like.and comments pls","text":"Like.and comments pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/128641808","repostId":"2145012425","repostType":4,"repost":{"id":"2145012425","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1624509732,"share":"https://www.laohu8.com/m/news/2145012425?lang=&edition=full","pubTime":"2021-06-24 12:42","market":"hk","language":"en","title":"HK-listed Agile climbs most in 5 weeks on theme park project with Melco","url":"https://stock-news.laohu8.com/highlight/detail?id=2145012425","media":"Reuters","summary":"** Shares of China's property developer Agile Group Holdings Ltd climb 2.4% to HK$10.36, the biggest","content":"<p>** Shares of China's property developer Agile Group Holdings Ltd climb 2.4% to HK$10.36, the biggest intraday percentage gain since May 18</p>\n<p>** Agile teams up a unit of Melco International Development&nbsp;to jointly develop mixed-use properties, including a theme park, on a piece of land in Zhongshan City in Guangdong province with aggregate investment of 6.05 bln yuan ($933.63 mln)</p>\n<p>** Shares of Melco gain 0.1% to HK$14.02, on track to snap two straight sessions of decline</p>\n<p>** The Hong Kong composite Industry Index tracking properties and construction stocks&nbsp;gains 0.6%</p>\n<p>** The Hang Seng China Enterprises Index slips 0.1% while the benchmark index&nbsp;climbs 0.02%</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HK-listed Agile climbs most in 5 weeks on theme park project with Melco</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHK-listed Agile climbs most in 5 weeks on theme park project with Melco\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-24 12:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>** Shares of China's property developer Agile Group Holdings Ltd climb 2.4% to HK$10.36, the biggest intraday percentage gain since May 18</p>\n<p>** Agile teams up a unit of Melco International Development&nbsp;to jointly develop mixed-use properties, including a theme park, on a piece of land in Zhongshan City in Guangdong province with aggregate investment of 6.05 bln yuan ($933.63 mln)</p>\n<p>** Shares of Melco gain 0.1% to HK$14.02, on track to snap two straight sessions of decline</p>\n<p>** The Hong Kong composite Industry Index tracking properties and construction stocks&nbsp;gains 0.6%</p>\n<p>** The Hang Seng China Enterprises Index slips 0.1% while the benchmark index&nbsp;climbs 0.02%</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"00200":"新濠国际发展","03383":"雅居乐集团"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2145012425","content_text":"** Shares of China's property developer Agile Group Holdings Ltd climb 2.4% to HK$10.36, the biggest intraday percentage gain since May 18\n** Agile teams up a unit of Melco International Development to jointly develop mixed-use properties, including a theme park, on a piece of land in Zhongshan City in Guangdong province with aggregate investment of 6.05 bln yuan ($933.63 mln)\n** Shares of Melco gain 0.1% to HK$14.02, on track to snap two straight sessions of decline\n** The Hong Kong composite Industry Index tracking properties and construction stocks gains 0.6%\n** The Hang Seng China Enterprises Index slips 0.1% while the benchmark index climbs 0.02%","news_type":1},"isVote":1,"tweetType":1,"viewCount":263,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":185221809,"gmtCreate":1623654870901,"gmtModify":1631893946628,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/185221809","repostId":"1165811803","repostType":4,"isVote":1,"tweetType":1,"viewCount":141,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":125407689,"gmtCreate":1624683557641,"gmtModify":1631893946601,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Hmmm","listText":"Hmmm","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/125407689","repostId":"1108941456","repostType":4,"repost":{"id":"1108941456","pubTimestamp":1624664800,"share":"https://www.laohu8.com/m/news/1108941456?lang=&edition=full","pubTime":"2021-06-26 07:46","market":"us","language":"en","title":"Is Apple A Better Buy Than Other FAANG Stocks?","url":"https://stock-news.laohu8.com/highlight/detail?id=1108941456","media":"seekingalpha","summary":"Apple undoubtedly is a great company, with a strong brand, excellent margins, and fundamentals, a fortress balance sheet, and massive shareholder returns.Being a great company does not mean that the stock must be a great buy. However, valuations are significantly higher than they were historically.I believe that some of the other FAANG stocks are better, while others are worse. AAPL seems like a solid, but not a spectacular investment at today's valuation.At 26-64x this year's expected net profi","content":"<p><b>Summary</b></p>\n<ul>\n <li>Apple undoubtedly is a great company, with a strong brand, excellent margins, and fundamentals, a fortress balance sheet, and massive shareholder returns.</li>\n <li>Being a great company does not mean that the stock must be a great buy. However, valuations are significantly higher than they were historically.</li>\n <li>I believe that some of the other FAANG stocks are better, while others are worse. AAPL seems like a solid, but not a spectacular investment at today's valuation.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8bb49d385ec6d3044db2f4474cbb2c57\" tg-width=\"1536\" tg-height=\"1024\" referrerpolicy=\"no-referrer\"><span>MagioreStock/iStock Editorial via Getty Images</span></p>\n<p><b>Article Thesis</b></p>\n<p>Going with FAANG stocks, i.e. Facebook (FB), Apple (AAPL), Amazon (AMZN), Netflix (NFLX), and Alphabet (GOOG)(GOOGL), has been a winning trade in recent years, as those companies delivered strong gains for their owners. These companies do, however, differ quite a lot from each other in a range of metrics, including growth, valuation, and there are also differences when it comes to each company's specific risks and moat. Apple is the largest company of these in terms of profits and market capitalization, but that does not necessarily make it the best investment. In this report, we will take a look at how Apple compares versus the other FAANG members.</p>\n<p><b>Are FAANG Stocks A Good Investment?</b></p>\n<p>Looking back a couple of years, the answer is pretty clear that FAANG stocks at least<i>were</i>a good investment in the recent past:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ae2b8e2b9caf99f74c28bafc10a0a872\" tg-width=\"635\" tg-height=\"484\"><span>Data by YCharts</span></p>\n<p>With gains of 200% to 460%, these five companies easily trounced the broad market's returns over the same time, and all led to hefty gains, at least tripling an investor's money in just five years. The factors that led to these strong gains do, at least partially, still exist today. Notably, these five companies are generating compelling earnings growth, have leadership positions in the markets they address, possess strong brands that are well-received by consumers, and seem to have strong, long-term-oriented leadership teams.</p>\n<p>These factors are still in place today, which indicates that FAANG stocks could also be good investments in coming years, although investors should, even with high-quality companies, also consider a stock's valuation. Today, these companies do not look extremely cheap in most cases:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2ef865eea7af4369048432a9c85d1d83\" tg-width=\"635\" tg-height=\"540\"><span>Data by YCharts</span></p>\n<p>At 26-64x this year's expected net profits, FAANG stocks can't really be called bargains, although the above-average valuations are, at least to some degree, justified due to the above-average earnings growth that these companies do generate. In any case, I doubt that investors owning FAANG stocks today will see 200%-400%+ returns over the next five years, as this seems unlikely for each of these five stocks due to the combination of current valuations and expected earnings growth. This does, however, not mean that FAANG stocks must be bad investments or underperform the market. In fact, in recent articles, I showcased that solid or even quite attractive returns can be expected from&nbsp;Facebook,Amazon, and Apple, even though the 30%-50% annual returns are likely a thing of the past - that's just mathematics, as no stock can grow at that rate forever.</p>\n<p><b>What Investors Can Expect From Apple</b></p>\n<p>Apple Inc. is not the highest-growth FAANG stock at all. Its growth has been solid but not spectacular in the recent past. This isn't a large surprise, as there is only a certain number of consumers that want to buy an iPhone or an iPad, and that amount can't grow by 50% a year for a very long time. Nevertheless, due to some market growth, some price increases, and growth from its services business, Apple should still be able to deliver sizeable revenue growth in the long run. New products such as the car project are a potential wildcard, but at least for the foreseeable future, this will not be a major profit center for the company. Apple also has a very ambitious shareholder return program, and its buybacks are an important factor for its future earnings per share growth. I believe that, overall, a high-single-digit earnings per share growth rate will be very much achievable for Apple in the long run. Combined with some multiple depression that I expect in coming years, as Apple will likely not trade at a high-20s earnings multiple forever, this gets me to a total return estimate&nbsp;in the 7% range. This is significantly less compared to what investors saw over the last couple of years, but on the other hand, 7% annual returns stemming from a strong, stable blue-chip stock such as Apple are not unattractive. I believe that some of the FAANG stocks could deliver stronger returns, primarily Alphabet and Facebook.</p>\n<p><b>Apple Versus Facebook</b></p>\n<p>Both Apple Inc. and Facebook have a great market position, but Facebook is even more dominant in its industry compared to Apple. Apple has, in the smartphone industry, a market share of around 20%, although more in the higher-end segments. Facebook, for comparison, owns four out of the top five social media networks, with Facebook, Instagram, Facebook Messenger, and WhatsApp. Clearly, FB absolutely dominates its industry. Facebook's industry is also growing quicker than the hardware IT markets that Apple serves, which is why Facebook's growth was significantly higher than Apple's growth in the recent past:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8fd8043ca75dcb2c38f5ffa427c8c0b9\" tg-width=\"635\" tg-height=\"433\"><span>Data by YCharts</span></p>\n<p>Facebook grew its revenue by well above 300% over the last five years, while Apple's revenue grew by a little less than 50%. When we look back at the total return chart at the beginning of this article and compare it to this revenue chart, we see that Apple's returns stemmed from multiple expansion to a large degree, whereas Facebook's stock actually got less expensive over the last five years. Facebook's business growth clearly outpaced its share price gains, which has made its shares less expensive. This also explains why Facebook, today, trades below the long-term median earnings multiple, whereas Apple's valuation is at the higher end of the historic range:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d3d49e0007aa77608b2992a9fef2142d\" tg-width=\"635\" tg-height=\"481\"><span>Data by YCharts</span></p>\n<p>The fact that Facebook trades at a historic discount points to a solid entry price, whereas the same can't be said about Apple. On top of that, Facebook will also grow much faster in the future - at least if the analyst community is correct:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6b16c9b3e2eac182d42686bcd8a98fc5\" tg-width=\"635\" tg-height=\"515\"><span>Data by YCharts</span></p>\n<p>While Apple is expected to see revenue growth of around 10% over the next two years, Facebook is expected to grow by 40% over the same time. Facebook's earnings per share growth estimate is also materially higher than that of Apple.</p>\n<p>To sum things up, we can say that Facebook is growing much faster, is even more dominant in its industry compared to Apple, and its shares are trading at a discount compared to the historic average, whereas Apple's shares are historically expensive. This combination makes me believe that the total return outlook for Facebook is better compared to that of Apple.</p>\n<p><b>Apple Versus Alphabet</b></p>\n<p>When we compare Apple to Alphabet, the comparison is relatively similar to what we just saw when comparing Applet to Facebook. Alphabet is a company that is growing quicker than Apple, and that can, to a large degree, be explained by its great market position and the higher market growth rate. Online advertising is a market that has been growing quicker than the tablet or smartphone market in recent years, and the same will, I believe, be true in the foreseeable future as well.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6360514d097081c546a0ccacfbdc7af6\" tg-width=\"635\" tg-height=\"450\"><span>Data by YCharts</span></p>\n<p>Alphabet is forecasted to grow its revenue by more than 30% over the next two years, versus Apple's 10% growth. On top of that, at close to 20%, Alphabet is also expected to grow its earnings per share at a higher rate.</p>\n<p>Nevertheless, despite its significantly better growth forecast, Alphabet isn't a lot more expensive compared to Apple. GOOG trades at 29x forward earnings, versus AAPL's 26x forward earnings multiple. Does it make sense for GOOG to trade at a premium of just 10%, while its expected growth is one and a half times as high as that of AAPL? You be the judge, but to me, it seems like the valuation looks better at Alphabet as long as we account for the stronger growth expectations. On top of that, with a net cash position of around $120 billion, Alphabet also has one of the best balance sheets in the world. Apple, for comparison, has a somewhat<i>smaller</i>net cash position of $80 billion, although that still makes for a very strong balance sheet, of course.</p>\n<p>All in all, we can summarize that Alphabet is growing faster today, is expected to grow significantly faster in the next two years and in the long run, has an even better balance sheet and a more dominant market position, and yet it trades at an earnings multiple that is only 10% higher than that of Apple. To me, Alphabet thus looks like the more attractive pick among these two at current prices.</p>\n<p><b>Apple Versus Netflix And Amazon</b></p>\n<p>Looking at the last two remaining companies in the FAANG group, we see that, once again, AAPL is growing at a slower pace. Unless Facebook and Alphabet, however, both Netflix and Amazon are way more expensive than Apple.</p>\n<p>This huge valuation premium offsets, at least to some degree, the higher expected growth, which is why I believe that Netflix and Amazon do not really seem like much better picks compared to Apple:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6ccc2536fa3cadf06639a89e0b211b9a\" tg-width=\"635\" tg-height=\"481\"><span>Data by YCharts</span></p>\n<p>AMZN and NFLX trade at PEG ratios of 1.8 and 1.9, which does not represent a clear discount compared to AAPL's valuation. On top of that, these two companies do not possess balance sheets that are as strong as that of Apple.</p>\n<p>Netflix, especially, looks significantly worse compared to the other FAANG members in terms of balance sheet strength and cash generation:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9d84f013051fbb00b6b488f5cfed66d4\" tg-width=\"635\" tg-height=\"450\"><span>Data by YCharts</span></p>\n<p>Netflix is the only FAANG member with a meaningful net debt position, and its free cash flows are equal to just 1% of its market capitalization. Netflix grows fast, but to me, it seems doubtful whether the current valuation is justified. Considering that more and more companies are pushing into the streaming market, including Disney (DIS), Amazon, and AT&amp;T(NYSE:T), more competition might hurt Netflix's margins in the future. NFLX thus seems like the worst pick among the five FAANG stocks to me, as it combines a high valuation, weak cash flows, and a somewhat uncertain competitive picture, and I think that is not fully negated by its strong growth alone.</p>\n<p>Amazon has a better market position than Netflix, a better balance sheet, and its valuation, relative to its growth, is a little lower than that of Netflix. I would rate Amazon as more or less equally attractive to Apple, although the two companies are quite different from each other in terms of growth, valuation, and shareholder returns.</p>\n<p><b>Which Is The Best FAANG Stock To Buy?</b></p>\n<p>Not every investor has the same goals, thus the answer may be different depending on what you are looking for in a stock. To me, Apple seems like a solid, but outstanding pick at current prices - the business undoubtedly is strong, the balance sheet is great, shareholder returns are hefty, but the valuation seems stretched, especially when we consider how cheap shares were in the past.</p>\n<p>Alphabet and Facebook do seem like the best FAANG picks to me today, as they combine strong growth with valuations that are only marginally higher than that of Apple. On top of that, both Alphabet and Facebook dominate their markets. Amazon is a stock that I would rate as a solid investment at today's price, so more or less in line with AAPL, whereas Netflix seems like the weakest pick among these five to me.</p>\n<p>Depending on your time horizon, appetite for risk, etc. you may disagree, however - and that's perfectly fine. I'd be glad to hear your top picks and reasoning in the comment section!</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Apple A Better Buy Than Other FAANG Stocks?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Apple A Better Buy Than Other FAANG Stocks?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-26 07:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4436558-apple-better-buy-faang-stocks><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nApple undoubtedly is a great company, with a strong brand, excellent margins, and fundamentals, a fortress balance sheet, and massive shareholder returns.\nBeing a great company does not mean ...</p>\n\n<a href=\"https://seekingalpha.com/article/4436558-apple-better-buy-faang-stocks\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://seekingalpha.com/article/4436558-apple-better-buy-faang-stocks","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108941456","content_text":"Summary\n\nApple undoubtedly is a great company, with a strong brand, excellent margins, and fundamentals, a fortress balance sheet, and massive shareholder returns.\nBeing a great company does not mean that the stock must be a great buy. However, valuations are significantly higher than they were historically.\nI believe that some of the other FAANG stocks are better, while others are worse. AAPL seems like a solid, but not a spectacular investment at today's valuation.\n\nMagioreStock/iStock Editorial via Getty Images\nArticle Thesis\nGoing with FAANG stocks, i.e. Facebook (FB), Apple (AAPL), Amazon (AMZN), Netflix (NFLX), and Alphabet (GOOG)(GOOGL), has been a winning trade in recent years, as those companies delivered strong gains for their owners. These companies do, however, differ quite a lot from each other in a range of metrics, including growth, valuation, and there are also differences when it comes to each company's specific risks and moat. Apple is the largest company of these in terms of profits and market capitalization, but that does not necessarily make it the best investment. In this report, we will take a look at how Apple compares versus the other FAANG members.\nAre FAANG Stocks A Good Investment?\nLooking back a couple of years, the answer is pretty clear that FAANG stocks at leastwerea good investment in the recent past:\nData by YCharts\nWith gains of 200% to 460%, these five companies easily trounced the broad market's returns over the same time, and all led to hefty gains, at least tripling an investor's money in just five years. The factors that led to these strong gains do, at least partially, still exist today. Notably, these five companies are generating compelling earnings growth, have leadership positions in the markets they address, possess strong brands that are well-received by consumers, and seem to have strong, long-term-oriented leadership teams.\nThese factors are still in place today, which indicates that FAANG stocks could also be good investments in coming years, although investors should, even with high-quality companies, also consider a stock's valuation. Today, these companies do not look extremely cheap in most cases:\nData by YCharts\nAt 26-64x this year's expected net profits, FAANG stocks can't really be called bargains, although the above-average valuations are, at least to some degree, justified due to the above-average earnings growth that these companies do generate. In any case, I doubt that investors owning FAANG stocks today will see 200%-400%+ returns over the next five years, as this seems unlikely for each of these five stocks due to the combination of current valuations and expected earnings growth. This does, however, not mean that FAANG stocks must be bad investments or underperform the market. In fact, in recent articles, I showcased that solid or even quite attractive returns can be expected from Facebook,Amazon, and Apple, even though the 30%-50% annual returns are likely a thing of the past - that's just mathematics, as no stock can grow at that rate forever.\nWhat Investors Can Expect From Apple\nApple Inc. is not the highest-growth FAANG stock at all. Its growth has been solid but not spectacular in the recent past. This isn't a large surprise, as there is only a certain number of consumers that want to buy an iPhone or an iPad, and that amount can't grow by 50% a year for a very long time. Nevertheless, due to some market growth, some price increases, and growth from its services business, Apple should still be able to deliver sizeable revenue growth in the long run. New products such as the car project are a potential wildcard, but at least for the foreseeable future, this will not be a major profit center for the company. Apple also has a very ambitious shareholder return program, and its buybacks are an important factor for its future earnings per share growth. I believe that, overall, a high-single-digit earnings per share growth rate will be very much achievable for Apple in the long run. Combined with some multiple depression that I expect in coming years, as Apple will likely not trade at a high-20s earnings multiple forever, this gets me to a total return estimate in the 7% range. This is significantly less compared to what investors saw over the last couple of years, but on the other hand, 7% annual returns stemming from a strong, stable blue-chip stock such as Apple are not unattractive. I believe that some of the FAANG stocks could deliver stronger returns, primarily Alphabet and Facebook.\nApple Versus Facebook\nBoth Apple Inc. and Facebook have a great market position, but Facebook is even more dominant in its industry compared to Apple. Apple has, in the smartphone industry, a market share of around 20%, although more in the higher-end segments. Facebook, for comparison, owns four out of the top five social media networks, with Facebook, Instagram, Facebook Messenger, and WhatsApp. Clearly, FB absolutely dominates its industry. Facebook's industry is also growing quicker than the hardware IT markets that Apple serves, which is why Facebook's growth was significantly higher than Apple's growth in the recent past:\nData by YCharts\nFacebook grew its revenue by well above 300% over the last five years, while Apple's revenue grew by a little less than 50%. When we look back at the total return chart at the beginning of this article and compare it to this revenue chart, we see that Apple's returns stemmed from multiple expansion to a large degree, whereas Facebook's stock actually got less expensive over the last five years. Facebook's business growth clearly outpaced its share price gains, which has made its shares less expensive. This also explains why Facebook, today, trades below the long-term median earnings multiple, whereas Apple's valuation is at the higher end of the historic range:\nData by YCharts\nThe fact that Facebook trades at a historic discount points to a solid entry price, whereas the same can't be said about Apple. On top of that, Facebook will also grow much faster in the future - at least if the analyst community is correct:\nData by YCharts\nWhile Apple is expected to see revenue growth of around 10% over the next two years, Facebook is expected to grow by 40% over the same time. Facebook's earnings per share growth estimate is also materially higher than that of Apple.\nTo sum things up, we can say that Facebook is growing much faster, is even more dominant in its industry compared to Apple, and its shares are trading at a discount compared to the historic average, whereas Apple's shares are historically expensive. This combination makes me believe that the total return outlook for Facebook is better compared to that of Apple.\nApple Versus Alphabet\nWhen we compare Apple to Alphabet, the comparison is relatively similar to what we just saw when comparing Applet to Facebook. Alphabet is a company that is growing quicker than Apple, and that can, to a large degree, be explained by its great market position and the higher market growth rate. Online advertising is a market that has been growing quicker than the tablet or smartphone market in recent years, and the same will, I believe, be true in the foreseeable future as well.\nData by YCharts\nAlphabet is forecasted to grow its revenue by more than 30% over the next two years, versus Apple's 10% growth. On top of that, at close to 20%, Alphabet is also expected to grow its earnings per share at a higher rate.\nNevertheless, despite its significantly better growth forecast, Alphabet isn't a lot more expensive compared to Apple. GOOG trades at 29x forward earnings, versus AAPL's 26x forward earnings multiple. Does it make sense for GOOG to trade at a premium of just 10%, while its expected growth is one and a half times as high as that of AAPL? You be the judge, but to me, it seems like the valuation looks better at Alphabet as long as we account for the stronger growth expectations. On top of that, with a net cash position of around $120 billion, Alphabet also has one of the best balance sheets in the world. Apple, for comparison, has a somewhatsmallernet cash position of $80 billion, although that still makes for a very strong balance sheet, of course.\nAll in all, we can summarize that Alphabet is growing faster today, is expected to grow significantly faster in the next two years and in the long run, has an even better balance sheet and a more dominant market position, and yet it trades at an earnings multiple that is only 10% higher than that of Apple. To me, Alphabet thus looks like the more attractive pick among these two at current prices.\nApple Versus Netflix And Amazon\nLooking at the last two remaining companies in the FAANG group, we see that, once again, AAPL is growing at a slower pace. Unless Facebook and Alphabet, however, both Netflix and Amazon are way more expensive than Apple.\nThis huge valuation premium offsets, at least to some degree, the higher expected growth, which is why I believe that Netflix and Amazon do not really seem like much better picks compared to Apple:\nData by YCharts\nAMZN and NFLX trade at PEG ratios of 1.8 and 1.9, which does not represent a clear discount compared to AAPL's valuation. On top of that, these two companies do not possess balance sheets that are as strong as that of Apple.\nNetflix, especially, looks significantly worse compared to the other FAANG members in terms of balance sheet strength and cash generation:\nData by YCharts\nNetflix is the only FAANG member with a meaningful net debt position, and its free cash flows are equal to just 1% of its market capitalization. Netflix grows fast, but to me, it seems doubtful whether the current valuation is justified. Considering that more and more companies are pushing into the streaming market, including Disney (DIS), Amazon, and AT&T(NYSE:T), more competition might hurt Netflix's margins in the future. NFLX thus seems like the worst pick among the five FAANG stocks to me, as it combines a high valuation, weak cash flows, and a somewhat uncertain competitive picture, and I think that is not fully negated by its strong growth alone.\nAmazon has a better market position than Netflix, a better balance sheet, and its valuation, relative to its growth, is a little lower than that of Netflix. I would rate Amazon as more or less equally attractive to Apple, although the two companies are quite different from each other in terms of growth, valuation, and shareholder returns.\nWhich Is The Best FAANG Stock To Buy?\nNot every investor has the same goals, thus the answer may be different depending on what you are looking for in a stock. To me, Apple seems like a solid, but outstanding pick at current prices - the business undoubtedly is strong, the balance sheet is great, shareholder returns are hefty, but the valuation seems stretched, especially when we consider how cheap shares were in the past.\nAlphabet and Facebook do seem like the best FAANG picks to me today, as they combine strong growth with valuations that are only marginally higher than that of Apple. On top of that, both Alphabet and Facebook dominate their markets. Amazon is a stock that I would rate as a solid investment at today's price, so more or less in line with AAPL, whereas Netflix seems like the weakest pick among these five to me.\nDepending on your time horizon, appetite for risk, etc. you may disagree, however - and that's perfectly fine. I'd be glad to hear your top picks and reasoning in the comment section!","news_type":1},"isVote":1,"tweetType":1,"viewCount":110,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166895084,"gmtCreate":1624000341948,"gmtModify":1631893946614,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Pls like and comment.&nbsp; Thanks","listText":"Pls like and comment.&nbsp; Thanks","text":"Pls like and comment. Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/166895084","repostId":"1149669763","repostType":4,"isVote":1,"tweetType":1,"viewCount":331,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":115173397,"gmtCreate":1622963925219,"gmtModify":1634096520622,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/115173397","repostId":"1102972710","repostType":4,"isVote":1,"tweetType":1,"viewCount":76,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":144127981,"gmtCreate":1626272599843,"gmtModify":1631893946598,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Good night bro","listText":"Good night bro","text":"Good night bro","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/144127981","repostId":"144126462","repostType":1,"repost":{"id":144126462,"gmtCreate":1626272507556,"gmtModify":1633928396670,"author":{"id":"3571397064539484","authorId":"3571397064539484","name":"Heibi","avatar":"https://static.tigerbbs.com/a4b0cb7e69d4c38018b1a3a840f08834","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571397064539484","authorIdStr":"3571397064539484"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Time to sleep lol gd night all 💎👐","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Time to sleep lol gd night all 💎👐","text":"$AMC Entertainment(AMC)$Time to sleep lol gd night all 💎👐","images":[{"img":"https://static.tigerbbs.com/5f51c54dc6d43d9c611bbc07ccb85dbf","width":"1284","height":"2457"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/144126462","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":290,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120330009,"gmtCreate":1624296497101,"gmtModify":1631883985890,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"The market pulled back after the latest Fed meeting on Wednesday, where policymakers signaled they expect to raise interest rates by late 2023, sooner than they had previously anticipated. The selloff intensified Friday after St. Louis Fed President James Bullard told CNBC he sees the Fed starting to raise interest rates in late 2022.Now is a time to be looking to add stocks to one's watchlist, but why do the stocks chosen above stand out? Before turning to that question, it is important to consider how one goes about choosing a stock in the first place. Superior fundamentals and technical action, and buying at the right time, are all part of a shrewd investing formula.","listText":"The market pulled back after the latest Fed meeting on Wednesday, where policymakers signaled they expect to raise interest rates by late 2023, sooner than they had previously anticipated. The selloff intensified Friday after St. Louis Fed President James Bullard told CNBC he sees the Fed starting to raise interest rates in late 2022.Now is a time to be looking to add stocks to one's watchlist, but why do the stocks chosen above stand out? Before turning to that question, it is important to consider how one goes about choosing a stock in the first place. Superior fundamentals and technical action, and buying at the right time, are all part of a shrewd investing formula.","text":"The market pulled back after the latest Fed meeting on Wednesday, where policymakers signaled they expect to raise interest rates by late 2023, sooner than they had previously anticipated. The selloff intensified Friday after St. Louis Fed President James Bullard told CNBC he sees the Fed starting to raise interest rates in late 2022.Now is a time to be looking to add stocks to one's watchlist, but why do the stocks chosen above stand out? Before turning to that question, it is important to consider how one goes about choosing a stock in the first place. Superior fundamentals and technical action, and buying at the right time, are all part of a shrewd investing formula.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/120330009","repostId":"2145084835","repostType":4,"repost":{"id":"2145084835","pubTimestamp":1624280460,"share":"https://www.laohu8.com/m/news/2145084835?lang=&edition=full","pubTime":"2021-06-21 21:01","market":"us","language":"en","title":"5 Ultra-Popular Stocks Wall Street Views as Overvalued","url":"https://stock-news.laohu8.com/highlight/detail?id=2145084835","media":"Motley Fool","summary":"If analysts are correct, these high-flying stocks will fizzle out over the next year.","content":"<p>Generally speaking, it pays to be bullish on Wall Street. Despite navigating its way through Black Monday in 1987, the dot-com bubble, the Great Recession, and more recently the coronavirus crash, the average annual total return for the benchmark <b>S&amp;P 500</b> since 1980, including dividends, is north of 11%.</p>\n<p>Not surprisingly, we see this optimism readily apparent in Wall Street's ratings on stocks. According to <b>FactSet</b>, more than half of all stocks carry a consensus buy rating, 38% have the equivalent of a hold rating, and just 7% are rated as sells. Yet, history shows that far more than 7% of stocks will eventually head lower.</p>\n<p>Based on Wall Street's consensus price targets, the following five ultra-popular stocks are all expected to lose value over the coming 12 months.</p>\n<p><img src=\"https://static.tigerbbs.com/b04ade705354c4825038c4dfcd0187d9\" tg-width=\"700\" tg-height=\"500\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Palantir Technologies: Implied downside of 12%</h3>\n<p>Since its direct listing in late September 2020, data-mining company <b>Palantir Technologies</b> (NYSE:PLTR) has been a favorite among growth and retail investors. But if Wall Street's <a href=\"https://laohu8.com/S/AONE\">one</a>-year consensus price target proves accurate, Palantir will head in reverse by up to 12%.</p>\n<p>The likeliest reason Wall Street is tempering expectations on Palantir is valuation. Specifically, Palantir ended June 17 with a market cap of nearly $48 billion, but is on track to bring in perhaps $1.5 billion in full-year sales in 2021. That's a multiple of about 32 times sales. Even if Palantir continues to grow its top-line at 30% annually, it could take years for this price-to-sales multiple to come down to anywhere close to the average for cloud stocks.</p>\n<p>Another possible concern is the growth potential for its government-focused Gotham platform. Big government contract wins in the U.S. have been primarily responsible for Palantir's exceptional growth rate. However, there remains an outside chance that President Joe Biden may curb funding to some of the federal agencies that employ Palantir's services.</p>\n<p>Over the long run, I'm optimistic and believe Palantir's platform is unlike anything else available. But tempering near-term expectations given its valuation premium may be warranted.</p>\n<p><img src=\"https://static.tigerbbs.com/a38605bee8e62f3e8aa414fa24278e7e\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Moderna: Implied downside of 11%</h3>\n<p>Biotech stock <b>Moderna</b> (NASDAQ:MRNA) is arguably the biggest beneficiary of the coronavirus disease 2019 (COVID-19) pandemic. It's <a href=\"https://laohu8.com/S/AONE.U\">one</a> of only three drugmakers to currently have their COVID-19 vaccine approved on an emergency-use authorization (EUA) basis in the United States. But if Wall Street's consensus 12-month price target is correct, it's stock is also on its way to a double-digit decline.</p>\n<p>Why the lack of love from Wall Street? The answer looks to be analysts looking to the future. While Moderna's COVID-19 vaccine is a mainstay in the U.S., and it's likely to play a clear role in other markets, time might prove the company's enemy. Over time, new vaccines are expected to come onto the scene, which'll eat away at Moderna's potential pool of patients.</p>\n<p>The other worry is that no one is exactly certain how long COVID-19 vaccine immunity will last. If it's a year, Moderna is unlikely to be the only drugmaker supplying booster shots. Meanwhile, if it's longer than a year, it means reduced sales opportunities for the company.</p>\n<p>Based solely on Wall Street's earnings per share consensus in 2021 and 2022, Moderna appears reasonably priced. But with the company staring down a potentially significant haircut in revenue next year as new drugmakers enter the space, caution is advised.</p>\n<p><img src=\"https://static.tigerbbs.com/07841e6a8173146a0fbfddf95a0f1ccb\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>GameStop: Implied downside of 71%</h3>\n<p>This will probably come as a shock to no one, but Reddit favorite <b>GameStop</b> (NYSE:GME) is fully expected to fall flat on its face. Even though Wall Street's consensus price target for the company has quintupled in recent months, it <i>still</i> implies up to 71% downside over the next year.</p>\n<p>The biggest issue for GameStop is that its valuation has completely detached from its underlying fundamentals. While it's not uncommon for stocks to trade on emotion for short periods of time, operating performance is what always dictates the long-term movement in the share price of a stock. When it comes to operating performance, GameStop has been a dud.</p>\n<p>Although the company's first-quarter fiscal results highlighted a 25% net sales increase from the prior-year period, total sales for the company have been falling precipitously for years. That's because video game retailer GameStop recognized the shift to digital gaming too late, and it's now stuck with its massive portfolio of brick-and-mortar gaming stores. Even though e-commerce sales have been a bright spot for the company, slashing costs and closing stores remains its No. 1 priority.</p>\n<p>With sufficient cash, bankruptcy isn't a concern for GameStop. But without any true top-line growth and the company still losing money, it's an impossible sell at its current price tag.</p>\n<p><img src=\"https://static.tigerbbs.com/c7ff785aa0040a5565d474390f58b47a\" tg-width=\"700\" tg-height=\"457\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Ocugen: Implied downside of 18%</h3>\n<p>Volatile clinical-stage biotech stock <b>Ocugen</b> (NASDAQ:OCGN) may also be in for an unpleasant next 12 months. The company behind an experimental COVID-19 vaccine (Covaxin) and a trio of internally developed eye-blindness candidates is expected to shed 18% of its value, if Wall Street's consensus price target is correct.</p>\n<p>Arguably the biggest issue for Ocugen is the clinical update the company issued on June 10 concerning Covaxin. Even though partner Bharat Biotech led a large clinical study in India that yielded an overall efficacy of 78%, along with 100% efficacy in preventing severe forms of COVID-19, Ocugen announced on June 10 that it would forgo seeking an EUA in the U.S. and would instead file for a biologics license application. In other words, Ocugen's path to a quick emergency approval in the U.S. just flew out the window.</p>\n<p>What's more, the U.S. Food and Drug Administration's requested additional information and data on Covaxin. This is a fancy of saying that Ocugen will very likely have to run a clinical study in the U.S. prior to submitting Covaxin for approval. That means added costs and an even longer wait before Ocugen has a chance to penetrate the lucrative U.S. market.</p>\n<p>Though it's impossible to predict how long COVID-19 vaccine immunity will last, Ocugen's chances of being a significant player in the U.S. COVID-19 vaccine space are dwindling.</p>\n<p><img src=\"https://static.tigerbbs.com/91f6037829ea3fb0ae1cae0b95d8d11e\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>NVIDIA: Implied downside of 3%</h3>\n<p>Don't adjust your computer, laptop, or smartphone screens -- that really says <b>NVIDIA</b> (NASDAQ:NVDA). Following its incredible run higher (NVIDIA has doubled over the past year), graphics processing unit giant NVIDIA closed 3% above Wall Street's consensus price target, as of June 17.</p>\n<p>One reason for tempered expectations at this point has to be valuation. Even with NVIDIA crushing expectations and seeing strong PC gaming demand, sales growth is expected to slow from an estimated 49% in fiscal 2022 to a high single digit percentage in each of the next two fiscal years. In fact, the company closed at nearly 20 times projected sales for the current fiscal year. That's a bit optimistic given an expected sales growth slowdown.</p>\n<p>Perhaps the other reason Wall Street expects NVIDIA to go sideways is the company's cryptocurrency mining chip segment. While sales of crypto chips could hit $400 million in the current quarter, demand is entirely dependent on the hype surrounding digital currencies and the favorability of technical charts. Crypto is just as well known for its long bear markets as it is for the big gains it's delivered over the past decade. If another lull strikes, a fast-growing ancillary segment for NVIDA could easily become a drag.</p>\n<p>For what it's worth, I see no fundamental reasons to sell NVIDIA if you're already a long-term shareholder. But if you're on the outside looking in, I don't exactly see $746 as an attractive entry point, either.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Ultra-Popular Stocks Wall Street Views as Overvalued</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Ultra-Popular Stocks Wall Street Views as Overvalued\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-21 21:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/21/5-ultra-popular-stocks-wall-street-view-overvalued/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Generally speaking, it pays to be bullish on Wall Street. Despite navigating its way through Black Monday in 1987, the dot-com bubble, the Great Recession, and more recently the coronavirus crash, the...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/21/5-ultra-popular-stocks-wall-street-view-overvalued/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc.","MRNA":"Moderna, Inc.","NVDA":"英伟达","OCGN":"Ocugen","GME":"游戏驿站"},"source_url":"https://www.fool.com/investing/2021/06/21/5-ultra-popular-stocks-wall-street-view-overvalued/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2145084835","content_text":"Generally speaking, it pays to be bullish on Wall Street. Despite navigating its way through Black Monday in 1987, the dot-com bubble, the Great Recession, and more recently the coronavirus crash, the average annual total return for the benchmark S&P 500 since 1980, including dividends, is north of 11%.\nNot surprisingly, we see this optimism readily apparent in Wall Street's ratings on stocks. According to FactSet, more than half of all stocks carry a consensus buy rating, 38% have the equivalent of a hold rating, and just 7% are rated as sells. Yet, history shows that far more than 7% of stocks will eventually head lower.\nBased on Wall Street's consensus price targets, the following five ultra-popular stocks are all expected to lose value over the coming 12 months.\n\nImage source: Getty Images.\nPalantir Technologies: Implied downside of 12%\nSince its direct listing in late September 2020, data-mining company Palantir Technologies (NYSE:PLTR) has been a favorite among growth and retail investors. But if Wall Street's one-year consensus price target proves accurate, Palantir will head in reverse by up to 12%.\nThe likeliest reason Wall Street is tempering expectations on Palantir is valuation. Specifically, Palantir ended June 17 with a market cap of nearly $48 billion, but is on track to bring in perhaps $1.5 billion in full-year sales in 2021. That's a multiple of about 32 times sales. Even if Palantir continues to grow its top-line at 30% annually, it could take years for this price-to-sales multiple to come down to anywhere close to the average for cloud stocks.\nAnother possible concern is the growth potential for its government-focused Gotham platform. Big government contract wins in the U.S. have been primarily responsible for Palantir's exceptional growth rate. However, there remains an outside chance that President Joe Biden may curb funding to some of the federal agencies that employ Palantir's services.\nOver the long run, I'm optimistic and believe Palantir's platform is unlike anything else available. But tempering near-term expectations given its valuation premium may be warranted.\n\nImage source: Getty Images.\nModerna: Implied downside of 11%\nBiotech stock Moderna (NASDAQ:MRNA) is arguably the biggest beneficiary of the coronavirus disease 2019 (COVID-19) pandemic. It's one of only three drugmakers to currently have their COVID-19 vaccine approved on an emergency-use authorization (EUA) basis in the United States. But if Wall Street's consensus 12-month price target is correct, it's stock is also on its way to a double-digit decline.\nWhy the lack of love from Wall Street? The answer looks to be analysts looking to the future. While Moderna's COVID-19 vaccine is a mainstay in the U.S., and it's likely to play a clear role in other markets, time might prove the company's enemy. Over time, new vaccines are expected to come onto the scene, which'll eat away at Moderna's potential pool of patients.\nThe other worry is that no one is exactly certain how long COVID-19 vaccine immunity will last. If it's a year, Moderna is unlikely to be the only drugmaker supplying booster shots. Meanwhile, if it's longer than a year, it means reduced sales opportunities for the company.\nBased solely on Wall Street's earnings per share consensus in 2021 and 2022, Moderna appears reasonably priced. But with the company staring down a potentially significant haircut in revenue next year as new drugmakers enter the space, caution is advised.\n\nImage source: Getty Images.\nGameStop: Implied downside of 71%\nThis will probably come as a shock to no one, but Reddit favorite GameStop (NYSE:GME) is fully expected to fall flat on its face. Even though Wall Street's consensus price target for the company has quintupled in recent months, it still implies up to 71% downside over the next year.\nThe biggest issue for GameStop is that its valuation has completely detached from its underlying fundamentals. While it's not uncommon for stocks to trade on emotion for short periods of time, operating performance is what always dictates the long-term movement in the share price of a stock. When it comes to operating performance, GameStop has been a dud.\nAlthough the company's first-quarter fiscal results highlighted a 25% net sales increase from the prior-year period, total sales for the company have been falling precipitously for years. That's because video game retailer GameStop recognized the shift to digital gaming too late, and it's now stuck with its massive portfolio of brick-and-mortar gaming stores. Even though e-commerce sales have been a bright spot for the company, slashing costs and closing stores remains its No. 1 priority.\nWith sufficient cash, bankruptcy isn't a concern for GameStop. But without any true top-line growth and the company still losing money, it's an impossible sell at its current price tag.\n\nImage source: Getty Images.\nOcugen: Implied downside of 18%\nVolatile clinical-stage biotech stock Ocugen (NASDAQ:OCGN) may also be in for an unpleasant next 12 months. The company behind an experimental COVID-19 vaccine (Covaxin) and a trio of internally developed eye-blindness candidates is expected to shed 18% of its value, if Wall Street's consensus price target is correct.\nArguably the biggest issue for Ocugen is the clinical update the company issued on June 10 concerning Covaxin. Even though partner Bharat Biotech led a large clinical study in India that yielded an overall efficacy of 78%, along with 100% efficacy in preventing severe forms of COVID-19, Ocugen announced on June 10 that it would forgo seeking an EUA in the U.S. and would instead file for a biologics license application. In other words, Ocugen's path to a quick emergency approval in the U.S. just flew out the window.\nWhat's more, the U.S. Food and Drug Administration's requested additional information and data on Covaxin. This is a fancy of saying that Ocugen will very likely have to run a clinical study in the U.S. prior to submitting Covaxin for approval. That means added costs and an even longer wait before Ocugen has a chance to penetrate the lucrative U.S. market.\nThough it's impossible to predict how long COVID-19 vaccine immunity will last, Ocugen's chances of being a significant player in the U.S. COVID-19 vaccine space are dwindling.\n\nImage source: Getty Images.\nNVIDIA: Implied downside of 3%\nDon't adjust your computer, laptop, or smartphone screens -- that really says NVIDIA (NASDAQ:NVDA). Following its incredible run higher (NVIDIA has doubled over the past year), graphics processing unit giant NVIDIA closed 3% above Wall Street's consensus price target, as of June 17.\nOne reason for tempered expectations at this point has to be valuation. Even with NVIDIA crushing expectations and seeing strong PC gaming demand, sales growth is expected to slow from an estimated 49% in fiscal 2022 to a high single digit percentage in each of the next two fiscal years. In fact, the company closed at nearly 20 times projected sales for the current fiscal year. That's a bit optimistic given an expected sales growth slowdown.\nPerhaps the other reason Wall Street expects NVIDIA to go sideways is the company's cryptocurrency mining chip segment. While sales of crypto chips could hit $400 million in the current quarter, demand is entirely dependent on the hype surrounding digital currencies and the favorability of technical charts. Crypto is just as well known for its long bear markets as it is for the big gains it's delivered over the past decade. If another lull strikes, a fast-growing ancillary segment for NVIDA could easily become a drag.\nFor what it's worth, I see no fundamental reasons to sell NVIDIA if you're already a long-term shareholder. But if you're on the outside looking in, I don't exactly see $746 as an attractive entry point, either.","news_type":1},"isVote":1,"tweetType":1,"viewCount":439,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":162305518,"gmtCreate":1624033327334,"gmtModify":1631893946610,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Good say. Oil is back","listText":"Good say. Oil is back","text":"Good say. Oil is back","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/162305518","repostId":"1138062216","repostType":4,"isVote":1,"tweetType":1,"viewCount":266,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183267572,"gmtCreate":1623333288296,"gmtModify":1634034477873,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Zhun bo","listText":"Zhun bo","text":"Zhun bo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/183267572","repostId":"1128810191","repostType":4,"repost":{"id":"1128810191","pubTimestamp":1623307595,"share":"https://www.laohu8.com/m/news/1128810191?lang=&edition=full","pubTime":"2021-06-10 14:46","market":"us","language":"en","title":"Company spending is 'going ballistic.' Wall Street analysts expect these stocks to benefit","url":"https://stock-news.laohu8.com/highlight/detail?id=1128810191","media":"cnbc","summary":"Firms are “flush with cash” and spending is at its highest in history, according to investment firmJefferies, which recommended dozens of U.S. and global stocks to play the trend.Jefferies’ capital expenditure — or capex — indicator is “going ballistic,” the bank said in a research note Monday, and there has been a surge in corporate spending on big-ticket goods such as ships, as well as on smaller items like plant equipment.Investment bankJPMorganalso picked stocks set to get a boost from the c","content":"<div>\n<p>Firms are “flush with cash” and spending is at its highest in history, according to investment firmJefferies, which recommended dozens of U.S. and global stocks to play the trend.\nJefferies’ capital ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/10/investment-banks-pick-top-industrials-and-tech-stocks-to-buy.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Company spending is 'going ballistic.' Wall Street analysts expect these stocks to benefit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCompany spending is 'going ballistic.' Wall Street analysts expect these stocks to benefit\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 14:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/10/investment-banks-pick-top-industrials-and-tech-stocks-to-buy.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Firms are “flush with cash” and spending is at its highest in history, according to investment firmJefferies, which recommended dozens of U.S. and global stocks to play the trend.\nJefferies’ capital ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/10/investment-banks-pick-top-industrials-and-tech-stocks-to-buy.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","SPY":"标普500ETF",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"source_url":"https://www.cnbc.com/2021/06/10/investment-banks-pick-top-industrials-and-tech-stocks-to-buy.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1128810191","content_text":"Firms are “flush with cash” and spending is at its highest in history, according to investment firmJefferies, which recommended dozens of U.S. and global stocks to play the trend.\nJefferies’ capital expenditure — or capex — indicator is “going ballistic,” the bank said in a research note Monday, and there has been a surge in corporate spending on big-ticket goods such as ships, as well as on smaller items like plant equipment.\nInvestment bankJPMorganalso picked stocks set to get a boost from the capital expenditure “bright spot.” It created two new lists of stocks likely to benefit from President Joe Biden’s $2.3 trillion infrastructure plan, as well as the E.U.’s 750 billion euro ($912 billion) recovery fund.\nThe banks’ stock picks include:\nIndustrials stocks\nMost of Jefferies buy-rated picks are industrials. It said U.S. firms were benefiting from a “huge turnaround” in capex and its picks include semiconductor firmAnalog Devicesand truck-makerPaccar. It also likes farm equipment companyJohn Deere, as well as air conditioning company Carrier Global.\nWhen it comes to international corporate spending, the analysts, led by Sean Darby, said: “We were wrong! It is not just the US that is enjoying a huge turnaround in capital investment intentions – even outside of Tech – but also the Rest-of-the-World.”\nJefferies’ international picks include Swedish leisure product manufacturerDometic Groupand German luxury RV-makerKnaus Tabbert, as well as Japanese firmHitachi Constructionand Chinese engineering firmChina Railway Group. All are buy-rated.\nEnergy and materials\nIn a note Monday, JPMorgan said it had put together two baskets of stocks: those set to benefit from President Biden’s infrastructure plan, and those likely to do well from the EU recovery fund. Firms that appear on both lists include steel firmArcelorMittaland Spanish energy companiesEDP RenewablesandIberdrola.\nTechnology and communications\nAnalysts from JPMorgan also picked semiconductor firmsInfineon TechnologiesandSTMicroelectronicsfor both their U.S. and European lists, as well as German firmDeutsche Telekom.\nFirms that appear on both Jefferies’ and JPMorgan’s lists include medical technology groupSiemens Healthineers, French train manufacturerAlstomand security firmAssa Abloy.\nA number of factors have combined to stimulate a capital spending surge, according to Jefferies’ analysts. These include old equipment that needs replacing, “buoyant” CEO confidence, an earnings turnaround leaving balance sheets “flush with cash,” and low industrial inventories.\n“Our US capex indicator has quite literally gone ballistic. It took around six years from the GFC [global financial crisis] to 2015 before a capex recovery emerged in the previous cycle. This one has taken approximately 13 months and has surged to the highest reading in history,” Jefferies’ analysts wrote.\nFor JPMorgan, company profits have also meant a surge in spending. “Corporate capex is on an accelerating path this year, given the strong rebound in corporate profitability, where profits have tended to lead capex pretty consistently. Further, bank lending standards are continuing to improve, which helps capex decisions,” the bank’s analysts wrote.","news_type":1},"isVote":1,"tweetType":1,"viewCount":40,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":180098584,"gmtCreate":1623163289348,"gmtModify":1634036257334,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Sad case for me&nbsp;","listText":"Sad case for me&nbsp;","text":"Sad case for me","images":[{"img":"https://static.tigerbbs.com/ddfa3fdd2e235373a5b97424619bef67","width":"1080","height":"2679"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/180098584","isVote":1,"tweetType":1,"viewCount":64,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}